Academic Papers
Sort by 1st author
Journal Articles
A
1983
Ackerman,
R.H., D'Alton, J.G., Davis, K.R., Hesselink, J.R., Donnan, G.A., Traveras,
J.M. Complementary roles of a non-invasive battery and digital subtraction
angiography in the evaluation of carotid disease. Amer. J. Neuroradiol.,
4:757-758, 1983.
1984
Ackerman, R.H., Alpert, N.M., Correia, J.A., Finkelstein, S., Davis,
S.M., Kelly, R.E., Donnan, G.A., D’Alton, J.G., Taveras, J.M.
Positron imaging in ischaemic stroke disease. Ann. Neurol., 15 (suppl):126-130,
1984.
19849
AUSTIMS
Research Group. Interferon-alpha and transfer factor in the treatment
of multiple sclerosis: a double-blind, placebo-controlled trial. J
Neurol Neurosurg Psychiatry 1989; 52: 566-574.
1992
Allen,
A.M., MacGregor, D.P., Chai, S.Y., Donnan, G.A., Kaczmarczyk, S.,
Richardson, K., Kalnins, R., Ireton, J., Mendelsohn, F.A. Angiotensin
II receptor binding associated with nigrostriatal dopaminergic neurons
in human basal ganglia. Ann. Neurol 32:339-344, 1992.
1994
Antiplatelet
Trialists’ Collaboration. Collaborative overview of randomised
trials of antiplatelet therapy I: Prevention of death, myocardial
infarction, and stroke by prolonged antiplatelet therapy in various
categories of patients. BMJ 308:81-106, 1994.
1998
Asia
Pacific Consensus Forum on Stroke Management. Organizing Committees
(Program, Advisory, and Local). Stroke 29:1730-1736, 1998.
2001
Albers,
G.W., Clark, W.M., Madden, K.P., Hamilton, S.A., Davis, S.M., Donnan,
G.A. ATLANTIS Trial: Results for patients treated within 3 hours of
stroke onset. Editorial comment. Stroke 33:493-496, 2001.
2002
Antithrombotic
Trialists’ Collaboration. Collaborative meta-analysis of randomised
trials of antiplatelet therapy for prevention of death, myocardial
infarction, and stroke in high risk patients. BMJ 324:71-86, 2002.
2005
Abbott AL, Chambers BR, Stork JL, Levi CR, Bladin CF, Donnan GA: Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke 36(6): 1128-1133, 2005.
Arakawa, S., Perera, N., Donnan, G.A. Neuroprotection
in Stroke. Advances in Clinical Neuroscience &
Rehabilitation. 2005.
2004
Allport LE, Butcher KS, Baird TA, MacGregor L, Desmond PM, Tress BM, Colman P, Davis SM: Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke 35(8): 1886-1891, 2004.
Amarenco P, Donnan GA: Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin? Stroke 35(11): 2606-2608, 2004.
2006
Abbott AL, Levi CR, Stork JL, Donnan GA, and
Chambers BR. Timing of clinically significant
microembolism following carotid endarterectomy.
Cerebrovascular Disease: Accepted, 2006.
Azarpazhooh MR and Chambers BR. Clinical
application of transcranial Doppler monitoring for
embolic signals. J Clin Neurosci 13: 799-810, 2006.
Amarenco P, Rother J, Michel P, Davis SM, Donnan GA: Aortic arch atheroma and the risk of stroke. Curr Atheroscler Rep 8(4): 343-346, 2006.
Arakawa S, Wright PM, Koga M, Phan TG, Reutens DC, Lim I, Gunawan MR, Ma H, Perera N, Ly J, Zavala J, Fitt G, Donnan GA: Ischemic thresholds for gray and white matter: a diffusion and perfusion magnetic resonance study. Stroke 37(5): 1211-1216, 2006.
Arima H, Tzourio C, Butcher K, Anderson C, Bousser MG, Lees KR, Reid JL, Omae T, Woodward M, Macmahon S, Chalmers J: Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial. Stroke 37(6): 1497-1502, 2006.
Azarpazhooh MR, Chambers BR: Clinical application of transcranial Doppler monitoring for embolic signals. J Clin Neurosci 13(8): 799-810, 2006.
2007
Abbott AL, Bladin C, Levi C, Chambers B: What should we do about asymptomatic carotid stenosis. International Journal of Stroke 2: 27-39, 2007.
Abbott AL, Levi CL, Stork JR, Donnan GA, Chambers BR: Timing of Clinically Significant Microembolism after Carotid Endarterectomy. Cerebrovasc Dis 23(5-6): 362-367, 2007.
Ali M, Bath PM, Curram J, Davis SM, Diener HC, Donnan GA, Fisher M, Gregson BA, Grotta J, Hacke W, Hennerici MG, Hommel M, Kaste M, Marler JR, Sacco RL, Teal P, Wahlgren NG, Warach S, Weir CJ, Lees KR: The Virtual International Stroke Trials Archive. Stroke, 2007.
B
1991
Baird,
A.E., Donnan, G.A., Austin, M., Newton, M.R., McKay, W.J. Preliminary
experience with 99mTc HMPAO SPECT in cerebral ischaemia. Clin. Exp.
Neurol., 28:43-49, 1991.
Baird,
A.E., Donnan, G.A., Saling, M. Mechanisms and clinical features of
internal watershed infarction. Clin. Exp. Neurol., 28:50-55, 1992.
1993
Baird,
A.E., Donnan, G.A. Prognostic value of reperfusion during first 48
hours of ischaemic stroke. Lancet 342:236, 1993.
Baird,
A.E., Donnan, G.A.. Increased 99mTc-HMPAO uptake in ischemic stroke.
Stroke, 24:1261-1262, 1993.
Bladin
CF; Chambers BR; Donnan GA. Confusing stroke terminology: watershed
or borderzone infarction? Stroke 1993; 24: 477-8
Bladin
CF, Chambers BR. Internal watershed infarction: clinical, CT, and
pathophysiological characteristics. Stroke 1993; 24: 1925-1932.
1994
Baird,
A.E., Donnan, G.A., Austin, M.C., Fitt, G.J., Davis, S.M., McKay,
W.J. Reperfusion after thrombolytic therapy in ischemic stroke measured
by single-photon emission computed tomography. Stroke 25:79-85, 1994.
Bladin
CF, Chambers BR. Frequency and pathogenesis of hemodynamic stroke.
Stroke 1994: 25; 2179-82.
1995
Baird,
A.E., Donnan, G.A., Austin, M.C., McKay, W.J. Early reperfusion in
the ‘spectacular shrinking deficit’ demonstrated by single-photon
emission computed tomography. Neurology 45:1335-1339, 1995.
1996
Baird,
A.E., Austin, M.C., McKay, W.J., Donnan, G.A. Changes in cerebral
tissue perfusion during the first 48 hours of ischaemic stroke: relationship
to clinical outcome. Journal of Neurology, Neurosurgery, and Psychiatry
61:26-29, 1996.
Bousser,
M.G., Chalmers, J., Cutler, J., Donnan, G.A., Hansson, L., Harrap,
S., Lisheng, L., MacMahon, S., Mancia, G., Menard, J., Omae, T., Reid,
J., Rodgers, A., Warlow, A. Blood pressure lowering for the secondary
prevention of stroke: Rationale and design for PROGRESS. Journal of
Hypertension 14(suppl 2):S41-S46, 1996.
Bousser,
M.G., Chalmers, J., Cutler, J., Donnan, G.A., Hansson, L., Harrap,
S., Lisheng, L., MacMahon, S., Mancia, G., Menard, J., Omae, T., Reid,
J., Rodgers, A., Warlow, A. PROGRESS Management Committee. PROGRESS
- Perindopril Protection Against Recurrent Stroke Study: Status in
July 1996. Journal of Hypertension 14:(suppl 6):S47-S51, 1996.
1997
Baird,
A., Donnan, G.A., Austin, M.C., McKay, W.J. Sensitivity and specificity
of 99mTc-HMPAO SPECT cerebral perfusion measurements during the first
48 hours for the localization of cerebral infarction. Stroke 28:976-980,
1997.
Bird,
M.R., Hii, S., McCrory, P.R., Donnan, G.A. Urinary incontinence in
eldery patients with acute stroke and hip fracture. MJA 167:415, 1997.
1998
Barber,
P.A., Darby, D.G., Desmond, P.M., Yang, Q., Gerraty, R.P., Jolley,
D., Donnan, G.A., Tress, B.M., Davis, S.M. Prediction of stroke outcome
with echoplanar perfusion- and diffusion-weighted MRI. Neurology 51;418-426,
1998.
Barber,
P.A., Davis, S.M., Infeld, B., Donnan, G.A., Baird, A.E., Jolley,
D., Lichtenstein M. Spontaneous reperfusion following ischemic stroke
is associated with improved outcomes. Stroke 29:2522-2528, 1998.
Bernhardt
J, Bate P, Matyas T. Accuracy of observational kinematic assessment
of upper-limb movements. Physical Therapy 78(3); 259-270, 1998.
Bernhardt J. Ellis P. Denisenko S. Changes in balance and locomotion measures during rehabilitation following stroke. Physiotherapy Research International. 3(2): 109-22, 1998.
Bladin,
C.F., Davis, S.M., Burton, K., Joffey, R., Storey, C.E., Donnan, G.A.
The use of percutaneous transluminal angioplasty (PTA) for the treatment
of extracranial atherosclerotic vascular disease - The Australian
Association of Neurologists (AAN). Aust NZ J Med 28:654-656, 1998.
1999
Baird A.E., Hennessy, O.F., Royal, J., Austin, M.C., McKay, W.J.,
Donnan, G.A. Asymmetries of cerebral perfusion in a stroke age population.
J. Clin. Neurosci. 6(2):113-120, 1999.
Baird,
A.E., Austin, M.C., O'Keefe, G.J., McKay, W.J., Donnan, G.A. Semiautomated
analysis of the extent and severity of perfusion defects on brain
SPECT images: validation studies. J Clin Neurosci 6(2):121-127, 1999.
Barber,
P.A., Darby, D.G., Desmond, P.M., Gerraty, R.P., Yang, Q., Li, T.,
Jolley, D., Donnan, G.A., Tress, B.M., Davis, S.M. Identification
of major ischemic change: Diffusion-weighted imaging versus computed
tomography. Stroke 30:2059-2065, 1999.
Barber,
P.A., Davis, S.M., Darby, D.G., Desmond, P.M., Gerraty, R.P., Yang,
Q., Jolley, D., Donnan, G.A., Tress, B.M. Absent middle cerebral artery
flow predicts the presence and evolution of the ischemic penumbra.
Neurology 52:1125-1132, 1999.
Batchelor,
P.E., Liberatore, G.T., Wong, J.Y.F., Porritt, M.J., Frerichs, F.,
Donnan, G.A., Howells, D.W. Activated macrophages and microglia induce
dopaminergic sprouting in the injured striatum and express brain-derived
neurotrophic factor and glial cell line-derived neurotrophic factor.
Journal of Neuroscience 19:1708-1716, 1999.
2000
Batchelor,
P.E., Liberatore, G.T., Porritt, M.J., Donnan, G.A., Howells, D.W.
Inhibition of brain-derived neurotrophic factor and glial cell line-derived
neurotrophic factor expression reduces dopaminergic sprouting in the
injured striatum. European Journal of Neuroscience 12:3462-3468, 2000.
Bladin
CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Cote R,
Lebrun L, Pirisi A, Norris JW. The Seizures after Stroke Study Group.
Seizures after stroke: a prospective, multi-centre study. Arch Neurol
2000; 57:1617-22.
2001
Bath,
P., Boysen, G., Donnan, G.A., Kaste, M., Lees, K.R., Olsen, T., Overgaard,
K., Sandercock, P., Wahlgren, N.G. Hypertension in acute stroke: What
do do? Stroke 32(7):1697-1698, 2001.
Bernhardt
J, Bate P, Matyas T. Training improves observation accuracy in novice
clinicians. Archives of Physical Medicine & Rehabilitation 82;
1611-1618, 2001.
2002
Baird
TA, Parsons MW, Barber A, Butcher KS, Desmond PM, Tress BM, Colman
PG, Jerums G, Chambers BR, Davis SM. The influence of diabetes mellitus
and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci
2002; 9: 618-26.
Batchelor,
P.E., Porritt, M.J., Nilsson, S.K., Bertoncello, I., Donnan, G.A.,
Howells, D.W. Peri-wound dopaminergic sprouting is dependent on the
number of wound macrophages. Eur J Neurosci 15:826-832, 2002.
Bernhardt
J, Matyas T, Bate P. Does clinical experience predict observational
kinematic assessment accuracy of upper limb movement pattern following
stroke? Physiotherapy Theory and Practice 18; 141 –149, 2002.
2003
Baird, T.A., Parsons, M.W., Phan, T., Butcher, K.S.,
Desmond, P.M., Tress, B.M., Colman, P., Chambers, B.R.,
Davis, S.M. Persistent post stroke hyperglycemia is
independently associated with infarct expansion and
worse clinical outcome. Stroke: 34: 2208-14, 2003.
Baird, A.D., Wilson, S.J., Bladin, P.F., Saling, M.M.,
Reutens, D.C. Sexual outcome after epilepsy surgery.
Epilepsy and Behaviour 2003.
Barber, P.A., Parsons, M.W., Desmond, P.M., Bennett,
D.A., Donnan, G.A., Tress, B.M., Davis, S.M. Use of PWI
and DWI Measures in the Design of “Proof of
Concept” Stroke Trials. Journal of Neuroimaging
2003.
Batchelor, P.E., Howells, D.W. CNS regeneration:
clinical possibility or basic science fantasy? J Clin
Neurosci. 10(5):523-34 2003.
Bernhardt, J, Thrift, A. Invited commentary.
Recreation in stroke rehabilitation part one: a review of the literature. Cowdell, F and Garrett, D. International Journal of Therapy and Rehabilitation. Vol 10 (9), 411. 2003.
Brodtmann, A.G., Puce, A., Syngeniotis, A., Darby, D.,
Donnan, G.A. Hemodynamic response to faces
remains stable until the ninth decade. NeuroImage
20:520-528, 2003.
Byrne, E., Howells, D.W. Stem cell therapies: a tale of
caution. Med J Aust 179:164-6, 2003. Howells, D.W.
Stem cells: do they replace or stimulate? Stroke
34:2082-3, 2003.
2004
Bernhardt J, Dewey H, Thrift A, Donnan G: Inactive and alone: physical activity within the first 14 days of acute stroke unit care. Stroke 35(4): 1005-1009, 2004.
Barber PA, Parsons MW, Desmond PM, Bennett DA, Donnan GA, Tress BM, Davis SM: The use of PWI and DWI measures in the design of "proof-of-concept" stroke trials. J Neuroimaging 14(2): 123-132, 2004.
2005
Bernhardt J, Borschmann K, Crock D, Hill K, McGann A, DeGori M: Stand up and be counted: Measuring time spent upright after hip fracture and comparison with community dwelling older people. Physiotherapy 91: 215-222, 2005.
Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress B, Donnan G, Davis S: Refining the perfusion-diffusion mismatch hypothesis. Stroke 36(6): 1153-1159, 2005.
2006
Bernhardt J, Dewey H, Collier J, Thrift A, Lindley R, Moodie M, Donnan G. A very early rehabilitation trial (AVERT). International Journal of Stroke. 1:169-171, 2006.
Bernhardt J, Dewey H, Collier J, Thrift A, Lindley R, Carter R, Donnan GA: About AVERT (A Very Early Rehabilitation Trial). International Journal of Stroke 1(3): 169-171, 2006.
Bernhardt JM: Improving health through health marketing. Prev Chronic Dis 3(3): A73, 2006.
Blennerhassett JM, Carey LM, Matyas TA: Grip force regulation during pinch grip lifts under somatosensory guidance: comparison between people with stroke and healthy controls. Arch Phys Med Rehabil 87(3): 418-429, 2006.
Blennerhassett, J.M., Carey, L.M., Matyas, T.A. (2006). Grip Force Regulation During Pinch Grip Lifts Under Somatosensory Guidance: Comparison Between People With Stroke and Healthy Controls. Archives of Physical Medicine and Rehabilitation. 87(3)418-429.
Bradshaw JM, Saling M, Anderson V, Hopwood M, Brodtmann A: Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer's type and controls. J Neurol Neurosurg Psychiatry 77(10): 1129-1135, 2006.
2007
Bernhardt J, Chan J, Nicola I, Collier JM. Little therapy, little physical activity: Rehabilitation within the first 14 days of organised stroke unit care. Journal of Rehabilitation Medicine. 39:43-48, 2007.
Bernhardt J, Dewey H, Collier J, Thrift A, Sharpley T, Donnan G. A very early rehabilitation trial (avert) phase ii safety and feasability results. Stroke. 38:473, 2007.
Bernhardt J, Dewey H, Collier J, Thrift A, Lindley R, Donnan G: Lancet Protocol Review: Protocol 06PRT/5424: A Very Early Rehabilitation Trial (AVERT): Phase III (Australian Clinical Trials Registry:1260600185561). The Lancet Published online, 2007.
Bernhardt J, Thrift AG. Invited commentary: Recreation in stroke rehabilitation part one: A review of the literature. International Journal of Therapy and Rehabilitation.10:411, 2007.
Bernhardt J. Advancing rehabilitation clinical trials design [Editorial]. International Journal of Therapy and Rehabilitation. 14:52;2007.
Blennerhassett JM, Matyas TA, Carey LM: Impaired discrimination of surface friction contributes to pinch grip deficit after stroke. Neurorehabil Neural Repair 21(3): 263-272, 2007.
Brodtmann A, Puce A, Darby D, Donnan G: fMRI demonstrates diaschisis in the extrastriate visual cortex. Stroke 38(8): 2360-2363, 2007.
Butcher KS, Lee SB, Parsons MW, Allport L, Fink J, Tress B, Donnan G, Davis SM: Differential prognosis of isolated cortical swelling and hypoattenuation on CT in acute stroke. Stroke 38(3): 941-947, 2007.
2008
Blennerhassett, J.M., Carey, L.M., Matyas, T.A. Impaired discrimination of sensory information about slip between object and skin is associated with handgrip limitation poststroke Brain Impairment. Special Issue: Stroke Rehabilitation. 9 (2):114-121. (Invited and peer reviewed). 2008.
Blennerhassett, J.M, Carey, L.M, Matyas, T.A. Clinical measures of handgrip limitation relate to impaired grip force control after stroke. Journal of Hand Therapy 21(3): 245-52; quiz 253. 2008.
Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G: A Very Early Rehabilitation Trial for Stroke (AVERT) Phase II Safety and Feasibility. Stroke, 2008.
C
1980
Chambers
BR, Donnan GA, Riddell J, Bladin PF. Carotidynia - aetiology, diagnosis
and treatment. Clin Exp Neurol 1980; 17: 113-123.
1981
Chambers
BR, Bladin PF, McGrath K, Goble AJ. Stroke syndromes in young people.
Clin Exp Neurol 1981; 18:132-144.
Chambers,
B.R., Donnan, G.A., Riddell, R.J., Bladin, P.F. Carotidynia: aetiology,
diagnosis and treatment. Clin. Exp. Neurol., 17:113-123, 1981.
1982
Chambers
BR, Gresty MA. Effects of fixation and optokinetic stimulation on
vestibulo-ocular reflex suppression. J Neurol Neurosurg and Psychiatry
1982; 45: 998-1004.
1983
Chambers
BR, Ell JJ, Gresty MA. Case of downbeat nystagmus influenced by otolith
stimulation. Ann Neurol 1983; 13: 204-207.
Chambers
BR, Gresty MA. The relationship between disordered pursuit and vestibulo-ocular
reflex suppression. J Neurol Neurosurg and Psychiatry 1983; 46: 61-66.
Chambers
BR. Carotid Doppler ultrasonography and stroke. Modern Medicine of
Canada, 1983; 38: 1359-1363.
Chambers,
B.R., Donnan, G.A., Bladin, P.F. Patterns of stroke. An analysis of
the first 700 consecutive admissions to the Austin Hospital Stroke
Unit. Aust. N.Z. J. Med., 13:57-64, 1983.
1984
Chambers
BR, Norris JW. The case against surgery for asymptomatic carotid stenosis.
Stroke 1984; 15: 964-967.
1985
Chambers
BR, Mai M, Barber HO. Bilateral vestibular loss, oscillopsia and the
cervico-ocular reflex. Otolaryngol Head Neck Surg 1985; 93: 403-407.
Chambers
BR, Norris JW. Carotid bruit controversy. Arch Neurol 1985; 42: 423.
Chambers
BR, Norris JW. Clinical significance of asymptomatic neck bruits.
Neurology 1985; 35: 742-745.
1986
Chambers
BR, Norris JW. Outcome in patients with asymptomatic neck bruits.
N Engl J Med 1986; 315: 860-865.
1987
Chambers
BR, Norris JW, Shurvell BL, Hachinski VC. Prognosis of acute stroke.
Neurology 1987; 37: 221-225.
Cicuttini,
F.M., Hurley, S.F., McNeil, J.J., Forbes, A., Donnan, G.A., Salzberg,
M., Giles, G.G. Association of adult glioma with medical conditions,
family and reproductive history. International Journal of Cancer 70(vol
2):203-207,1997.
1988
Chambers
BR, Hughes AJ. Dementia, gait disturbance, incontinence and hydrocephalus.
Clin Exp Neurol 1988; 25: 43-51.
Chambers
BR. Middle cerebral artery velocity and risk of stroke. In Stroke,
Donnan GA, Berkovic SF, Vajda FJE (eds), University of Melbourne,
Melbourne, 1988, pp 77-79.
1989
Chambers
BR, Merory JR, Smidt V. Doppler diagnosis in cases of acute stroke.
Med J Aust 1989; 150:382-384.
1990
Chambers
BR. Carotid ultrasound in cerebrovascular disease. Australian Prescriber
1990; 13: 12-14.
Chambers
BR. Treating the evolving stroke. Patient Management 1990; 14: 29-32.
1991
Chambers,
B.R., Brooder, R., Donnan, G.A. Proximal posterior cerebral artery
occlusion simulating middle cerebral artery occlusion. Neurology,
41:385-390, 1991.
Cunningham,
M.A., Darby, D.G., Donnan, G.A. Controlled-release of L-dopa associated
with nonfatal hyperthermia, rigidity and autonomic dysfuction. Neurology,
41:942-943, 1991.
1992
Cher
LM; Chambers BR; Smidt V. Comparison of transcranial Doppler with
DSA in vertebrobasilar ischaemia. Clin Exp Neurol. 1992; 29: 143-8.
1993
Carey,
L. M., Matyas, T. A., & Oke, L. E. (1993). Sensory loss in stroke
patients: Effective tactile and proprioceptive discrimination training.
Archives of Physical Medicine and Rehabilitation, 74, 602-611.
Chambers
BR, O'Malley H, Levi CR, Bair A, Singh P, Donnan GA. Measurement of
recanalisation with transcranial Doppler in ischaemic stroke. New
Horizons in Epilepsy and Stroke. Proceedings of a special Joint Scientific
Meeting of the Stroke Society of Australasia and the Epilepsy Society
of Australia 1993, pp 345-349.
Churchyard,
A., Donnan, G.A., Kaczmarczyk, S.J., Hughes, A.H., Howells, D., Mendelsohn,
F.A.O. Dopa resistance in multiple system atrophy: Loss of postsynaptic
D2 receptors. Ann. Neurol. 34:219-226, 1993.
Cotton
R.G.H., D.W. Howells, J.A. Saleeba, I. Dianzani, P.M. Smooker, I.G.
Jennings. Structure function studies of the phenylalanine hydroxylase
active site and a summary of structural features. Adv.Exp. Med.Biol.
1993;338:55-7.
Cotton
R.G.H., H-H. Dahl, S.M. Forrest, D.W. Howells, S.J. Ramus, R.E. Bishop,
I. Dianzani, J.A. Saleeba, E. Palombo, M.J. Anderson, et al. Analysis
of sequence contexts flanking T.G mismatches leads to predictions
about reactivity of the mismatched T to osmium tetroxide. DNA &
Cell Biology 1993 Dec;12(10):945-9.
1994
Chambers
BR, Smidt VJ, Koh P. Hyperperfusion post-endarterectomy. Cerebrovasc
Dis 1994; 4: 32-37.
1995
Carey, L. M. (1995). Somatosensory loss after stroke. Critical Reviews
in Physical & Rehabilitation Medicine, 7, 51-91.
Chambers
BR, Bladin CB. Internal watershed infarction. In 'Lacunar and other
Subcortical Infarctions'. Eds Donnan GA, Norrving B, Bamford JM, Bougasslavsky
J. 1995, Oxford University Press, Melbourne, pp139-48.
Chambers
BR. Secondary prevention of stroke. Aust NZ J Med 1995; 25: 465-8.
1996
Cadilhac
D. (1996), Informed consent, Clinical Trials and the Neuroscience
Nurse”, Australasian Journal of Neuroscience. VOL 9 No 1, Jan-Mar.
Carey,
L. M., Oke, L. & Matyas, T. A. (1996). Impaired limb position
sense after stroke: A quantitative test for clinical use. Archives
of Physical Medicine & Rehabilitation, 77, 1271-8.
1997
Carey,
L. M., Oke, L. & Matyas, T. A. (1997). Impaired touch discrimination
after stroke: A quantitative test. Journal of Neurologic Rehabilitation,
11,219-232.
1998
Cadilhac,
D. (1998) The changing face of stroke: Medical management revolution.
Australian Nursing Journal. 5:18-21.
1999
Chambers
B, O’Malley H, Levi A, Baird A, Singh P, Donnan G. Measurement
of recanalisation with transcranial Doppler in ischaemic stroke. In
New Horizons in Epilepsy and Stroke: a Festschrift for Dr Peter Bladin.
Ed R Macdonell. Austin & Repatriation Medical Centre, Melbourne.
1999; Chap 39: 345-9.
Conner,
G., Donnan, G.A., Taylor, A. Clopidogrel (Plavix): Atherothrombosis
and the role of antiplatelet agents. MIMS Product Review - October/November,
Pg 1-14, 1999.
Cornu,
C., Boissel, J.P., Boutitie, F., Candelise, L., Donnan, G.A., Homel,
M., Lees, K.R. Thrombolysis in Acute Stroke Pooling Project: a meta-analysis
on individual patient data. Journal of Clinical Neuroscience 6(1):20-23,
1999.
2000
Cadilhac
D., D Pearce, M Di Pietro, G.Donnan, S Davis, R Carter, J McNeil,
R Walker, F Smarrelli (2000). Victorian Stroke Care: Delivery, Utilisation,
Quality, Costs and Outcomes, Health Outcomes for the Nation: Best
Bets and Best Buys, Canberra 2-3 August, Conference Proceedings CD-ROM
ISBN 0957776713.
Carey,
L., Abbott, D.F., Egan, G.F., Tochon-Danguy, H.J., Donnan, G.A. The
functional neuroanatomy and long term reproducibility of brain activation
associated with a simple finger tapping task in older healthy volunteers:
A serial PET study. NeuroImage 11:124-144, 2000.
Chambers
BR, You RX, Donnan GA. Carotid endarterectomy for asymptomatic carotid
stenosis (Cochrane Review). In: The Cochrane Library, Issue 1, 2000.
Oxford: Update Software.
Cornu,
C., Boutitie, F., Candelise, L., Boissel, J.P., Donnan, G.A., Hommel,
M., Jaillard, A., Lees, K.R. Streptokinase in acute ischemic stroke:
an individual patient data meta-analysis : The Thrombolysis in Acute
Stroke Pooling Project. Stroke 31(7):1555-60, 2000.
2001
CAVATAS
Investigators. Endovascular versus surgical treatment in patients
with carotid stenosis in the Carotid and Vertebral Artery Transluminal
Angioplasty Study (CAVATAS): a randomised trial. Lancet 357:1729-37,
2001.
2002
Cadilhac
D. (2002) How should stroke services be organised? Nursing Perspective-Australia.
The Lancet Neurology Vol 1 May pp 63-64.
Carey,
L.M. (2002). Occupational Therapy and Stroke: Book review. Australian
Occupational Therapy Journal.
Carey,
L.M., Abbott, D.F., Puce, A., Jackson, G.D., Syngeniotis, A., Donnan,
G.A. Reemergence of activation with poststroke somatosensory recovery:
a serial fMRI case study. Neurology 59:749-752, 2002.
Carey,
L.M., Matyas, T.A. & Oke, L.E.(2002). Evaluation of impaired fingertip
texture discrimintion and wrist position sense in patients affected
by stroke: Comparison of clinical and new quantitative measures. Journal
of Hand Therapy 15: 71-82.
Chambers,
BR, Bladin, CF. Internal Watershed Infarction. In Subcortical Stroke,
Oxford University Press 2nd Edition. Eds Donnan GA, Norrving B, Bamford
JM, Bougasslavsky J. 2002, Oxford University Press, Melbourne.
2003
Chalmers, J., Adams, H.P., Jr., Donnan, G.A., Fox, K.,
MacMahon, S., Mancia, G., Tzourio, C. Clinical
implications of PROGRESS: questions and answers. J
Hypertens Suppl 21 Suppl 5:S21-24, 2003.
Chambers, B.C., Stork, J., Kimura, K., Abbott, A., Levi,
C.R., Donnan, G.A. Symptomatic carotid artery
stenosis: Heterogeneity of destabilizing mechanisms?
Response. Stroke 34:E41-E41, 2003.
Chaturvedi, V., Patel, A., Chalmers, J., et al. Effects of a
perindopril-based blood pressure lowering regimen on
cardiac outcomes among patients with cerebrovascular disease. European Heart Journal
24:475-484, 2003.
2004
Cadilhac DA, Ibrahim J, Pearce DC, Ogden KJ, McNeill J, Davis SM, Donnan GA: Multicenter comparison of processes of care between Stroke Units and conventional care wards in Australia. Stroke 35(5): 1035-1040, 2004.
Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, Davis S, Donnan G, MacMahon S, Neal B, Warlow C, Woodward M: Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke 35(1): 116-121, 2004.
2005
Cadilhac D: More nurses should be encouraged to undertake research - an example from stroke. Intouch Newsletter of the Public Health Association of Australia 22: 10-11, 2005.
Cadilhac DA, Thorpe RD, Pearce DC, Barnes M, Rochford PD, Tarquinio N, Davis SM, Donnan GA, Pierce RJ: Sleep disordered breathing in chronic stroke survivors. A study of the long term follow-up of the SCOPES cohort using home based polysomnography. J Clin Neurosci 12(6): 632-637, 2005.
Carey LM, Abbott DF, Egan GF, Bernhardt J, Donnan GA: Motor impairment and recovery in the upper limb after stroke: behavioral and neuroanatomical correlates. Stroke 36(3): 625-629, 2005.
Carey LM, Matyas TA: Training of somatosensory discrimination after stroke: facilitation of stimulus generalization. Am J Phys Med Rehabil 84(6): 428-442, 2005.
Chambers BR, Donnan GA: Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev (4): CD001923, 2005.
2006
Cadilhac DA, Lalor EE, Pearce DC, Levi CR, Donnan GA: Access to stroke care units in Australian Public Hospitals: facts and temporal progress. Int Med Journal 36(11): 700-704, 2006.
Cadilhac DA, Moodie ML, Lalor EE, Bilney LE, Donnan GA: Improving access to evidence-based acute stroke services: development and evaluation of a health systems model to address equity of access issues. Aust Health Rev 30(1): 109-118, 2006.
Carey, L.M., Abbott, D.F., Egan, G.F., O’Keefe, G.J., Jackson, G.D., Bernhardt, J., Donnan, G.A. (2006) Evolution of brain activation with good and poor motor recovery after stroke. Neurorehabilitation and Neural Repair. 20:1-18. [IF = 3.823], 2006.
2007
Cadilhac DA, Carter RC, Thrift AG, Dewey HM: Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications. Health Policy 83(2-3): 287-294, 2007.
Carey L, Seitz R: Functional neuroimaging in stroke recovery and neurorehabilitatio: conceptual issues and perspectives. International Journal of Stroke 2(4): 245-264, 2007.
Carey, L.M. (2007). Neuroplasticity and learning lead a new era in stroke rehabilitation. International Journal of Therapy and Rehabilitation. 14(6), 200-201. (invited editorial), 2007.
Chambers BR, Roberts NG: Asymptomatic carotid artery stenosis. Curr Treat Options Cardiovasc Med 9(2): 81-89, 2007.
Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG: Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome? Neurology 68(20): 1687-1693, 2007.
2008
Cadilhac DA, Carter R, Thrift AG, Dewey HM. Estimating the long-term costs of ischemic (IS) and hemorrhagic (ICH) stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2008;Accepted 26 August.
Cadilhac DA, Pearce DC, Levi CR, Donnan GA. Improvements in the quality of care and health outcomes with new stroke care units following implementation of a clinician-led, health system redesign programme in New South Wales, Australia. Qual Saf Health Care 2008;17(5):329-33.
Carey LM, Abbott DF, Egan GF, Donnan GA: Reproducible activation in BA2, 1 and 3b associated with texture discrimination in healthy volunteers over time. Neuroimage 39(1): 40-51, 2008.
Carey, LM, Blennerhassett, J., Cadilhac, D., Douglas, J. Stroke Rehabilitation: Multidisciplinary Perspectives. Brain Impairment. Special Issue: Stroke Rehabilitation. 9 (2): 95-96. (guest editorial). 2008.
Carey, L.M., Matyas, T.A. Effectiveness of sensory discrimination training when delivered by family members. Brain Impairment. Special Issue: Stroke Rehabilitation. 9 (2):140-151. (Invited and peer reviewed). 2008.
Chen L, Rogers SL, Colagiuri S, Cadilhac DA, Mathew TH, Boyden AN, et al. How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000. Med J Aust 2008;189(6):319-322.
Cumming TB, Cadilhac DA, Rubin G, Crafti N, Pearce D. Psychological distress and social support in informal caregivers of stroke survivors. Brain Impairment Journal (accepted 24 April) 2008.
D
1978
Donnan,
G.A., McKay, W.J., Thomas, D.P., Bladin, P.F. Detection of experimental
carotid ulceration by radionuclide labelled particles. Clin. Exp.
Neurol. 15:174-181, 1978.
Donnan,
G.A., Walsh, K.W., Bladin, P.F. Memory disorder in vertebrobasilar
disease. Clin. Exp. Neurol., 15:215-220, 1978.
1979
Donnan,
G.A. Stuttering as a manifestation of stroke. Med. J. Aust., 1:44-45,
1979.
Donnan,
G.A., Bladin, P.F. The stroke syndrome of long intraluminal clots
with incomplete vessel obstruction. Clin. Exp. Neurol., 16:41-47,
1979.
Donnan,
G.A., Jarrott, B.J. Urticaria pigmentosa - a change in conscious state
associated with a rise in plasma histamine levels. Clin. Exp. Neurol.
16:191-195, 1979.
1980
Donnan,
G.A. The Neurological Examination. The Australian Family Physician
9: 434-437,1980.
Donnan,
G.A., Seeman, E. Coma and hypothermia in Wernicke's encephalopathy.
Aust. N.Z. J. Med., 10:438-439, 1980.
1982
Donnan,
G.A., Sharbrough, F.W., Whisnant, J.P. Carotid occlusive disease.
Effect of bright light on visual evoked response. Arch. Neurol., 39:687-698,
1982.
Donnan,
G.A., Tress, B.S., Bladin, P.F. A prospective study of lacunar infarction
using computerized tomography. Neurology, 32:49-56, 1982.
1985
Donnan,
G.A., Bladin, P.F., Woodward, J.M. The extracranial-intracranial by-pass
study: How will the outcome affect us? Aust. N.Z. J. Med., 15:386-391,
1985.
1986
Donnan,
G.A., Kaczmarczyk, S.J., Rowe, P.J., Figdor, R., Mendelsohn, F.A.O.
The effects of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine on presynaptic
uptake sites in the mouse striatum. J. Neurol. Sci., 74: 111-119,
1986.
Donnan,
G.A., Kaczmarczyk, S.J., Soloptias, T., Rowe P.J., Kalnins, R.M.,
Vajda F.J.E., Mendelsohn, F.A.O. The neurochemical and clinical effects
of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine in Small Animals.
Clin. Exp. Neurol. 22:155-164, 1986.
1987
Donnan
G.A., Bladin P.F. The Diagnosis and Management of Cerebral Vascular
Disease. Aust. Family Physician, 16:1749-1756, 1987.
Donnan,
G.A., Kaczmarczyk, S.J., McKenzie J.S., Rowe, P.J., Kalnins R.M.,
Mendelsohn, F.A.O. Regional and temporal effects of on dopamine uptake
sites in mouse brain. J. Neurol. Sci., 81:261-271, 1987.
Donnan,
G.A., Willis G.L., Kaczmarczyk, S.J., Rowe P.J. Motor function in
the 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine treated mouse. J.
Neurol. Sci., 77:185-191, 1987.
1988
Darby, D.G., Donnan G.A., Walsh K.W., Bladin P.F. Primary Intraventricular
Haemorrhage. Neurology, 38:68-75, 1988.
Donnan,
G.A. Cerebrovascular Disease in the Elderly. Your Ageing Patient,
9:14-17, 1988 (review by invitation).
1989
Davis,
S.M., Tress, B.M., Dowling, R., Donnan, G.A., Kiers, L., Rossiter,
S.C. Magnetic resonance imaging in posterior circulation infarction:
impact on diagnosis and management. Aust. N.Z. J. Med., 19:219-225,
1989.
Donnan,
G.A., Kaczmarczyk, S.J., McKenzie, J.S., Kalnins, R.M., Chilco, P.J.,
Mendelsohn, F.A.O. Catecholamine uptake sites in mouse brain: distribution
determined by quantitative [3H] mazindol autoradiography. Brain Res.,
504:64-71, 1989.
Donnan,
G.A., McNeil, J.J., Adena, M.A., Doyle, A.E., O'Malley, H.M., Neill
G.C. Smoking as a risk factor for cerebral ischaemia. Lancet, 2:643-647,
1989.
1990
Donnan,
G.A. Stroke: WHO task force findings. Current Therapeutics, June:37-41,
1990 (guest editorial).
Doyle,
A.E., Donnan, G.A. Stroke as a clinical problem in hypertension. Cardiovas.
Pharmacol., 15:S34-S37, 1990.
1991
Donnan,
G.A. Early intervention in acute stroke. Aust. Fam. Physician, 20:1575-1580,
1991 (review by invitation).
Donnan,
G.A. Therapy in cerebrovascular disease: Current status and future
directions. Med. J. Aust., 155:563-571, 1991 (review by invitation).
Donnan,
G.A., Bladin, P.F., Berkovic, S.F., Longley, W.A., Saling, M.M. The
stroke syndrome of striatocapsular infarction. Brain, 114:51-70, 1991.
Donnan,
G.A., Kaczmarczyk, S.J., Paxinos, G, Chilco, P.J, Woodhouse, D.G.,
Kalnins, R.M. Mendelsohn, F.A.O. The distribution of catecholamine
uptake sites in human brain determined by quantitative [3H] mazindol
autoradiography. J. Comp. Neurol., 304:419-434, 1991.
Donnan,
G.A., Woodhouse, D.G., Kaczmarczyk, S.J., Holder, J.E., Paxinos, G.,
Chilco, P.J., Churchyard, A.J., Kalnins, R.M., Fabinyi, G.C.A., Mendelsohn,
F.A.O. Evidence for Plasticity of the Dopaminergic System in Parkinsonism.
Molecular Neurobiol., 5:421-433, 1991.
1992
Donnan
GA. Acute stroke: A new era? (Editorial) Aust. NZ J Med., 22:3-4,
1992.
Donnan,
G.A. Anticoagulants for atrial fibrillation. Med. J. Aust., (leading
article by invitation) 157:77-78, 1992.
Donnan,
G.A. Investigations of patients with stroke and transient ischaemic
attacks. Lancet 339:473-477, 1992.
1993
Donnan
G.A. Cerebral Angiography: Angiography, air embolism, and ultrasound.
Lancet, 341: 796, 1993.
Donnan
G.A. Lifesaving for stroke. Lancet 342:383-384, 1993.
Donnan
GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, Stewart-Wynne EG,
Rosen D, Tuck RR, McNeil JJ. Australian Streptokinase Trial (ASK).
In 'Thrombolytic Therapy in Acute Ischemic Stroke II'. Eds del Zoppo
GJ, Mori E, Hacke W. Springer-Verlag, Berlin, Heidelberg. 1993; 80-85.
Donnan,
G.A., Norrving, B., Bamford, J., Bogousslavsky, J. Classification
and terminology for subcortical infarction. Stroke International,
4:6-9, 1993.
Donnan,
G.A., Norrving, B., Bamford, J.M., Bogousslavsky, J. Subcortical infarction:
Classification and terminology. Cerebrovascular Diseases 3:248-251,
1993.
Donnan,
G.A., O'Malley, H., Hurley, S., Quang, L.C., Bladin, P.F. The capsular
warning syndrome: pathogenesis and clinical features. Neurology, 43:957-962,
1993.
Donnan,
G.A., You, R.X., Thrift, A. Smoking as a risk factor for cerebral
ischaemia. Cerebrovascular Diseases 3:129-138, 1993.
Donnan,
G.A., Zapf, P., Doyle, A.E., Bladin, P.F. CSF enzymes in lacunar and
cortical stroke. Stroke, 14:266-269, 1983.
1994
Donnan,
G.A., Thrift, M., You, R., McNeil, J.J. Hypertension and stroke. Journal
of Hypertension 12: 865-869, 1994.
Donnan,
G.A., Baird, A.E., Levi, C.R. Diagnosis and imaging of stroke. Journal
of Hypertension 12: S15-S18, 1994.
Donnan,
G.A., You, R., Thrift, M., McNeil, J.J., Johnston, C.I. Hypertension
as a Risk factor for Stroke Subtypes. Hypertension Research 17: S51-S54,
1994.
1995
Davis,
S.M., Donnan, G.A. Patients, Centres, Admission Procedures and Non-Randomized
Treatments around the world. Cerebrovasc Dis 5(suppl 1):16-21, 1995.
Donnan
GA, Davis SM, Chambers BR, et al. Australian Streptokinase Trial:
Progress Report. In ‘Thrombolytic Therapy in Acute Ischemic Stroke
III’. Yamaguchi T, Mori E, Minematsu K, del Zoppo GJ (Eds) Springer-Verlag,
Tokyo, 1995; 214-217.
Donnan
GA, Davis SM, Chambers BR, et al. Trials of streptokinase in severe
acute ischaemic stroke. Lancet 1995; 345: 578-9.
Donnan,
G.A. (Guest Editor) Risk factors for stroke: What progress are we
making? Cardiovascular Risk Factors (editorial) Vol 5, No.6:317-318,
1995.
Donnan,
G.A., Davis, S.M. Stroke: progress at last? The Medical Journal of
Aust. 163:343-344, 1995.
Donnan,
G.A., Davis, S.M., Chambers, B.R. Gates, P.C., Hankey, G.J., McNeill,
J.J., Rosen, D., Stewart-Wynne, E.G., Tuck, R.R. Trials of streptokinase
in severe actue ischaemic stroke. Lancet 345:578-579, 1995.
Donnan,
G.A., Hommel, M., Davis, S.M., McNeil, J.J. Streptokinase in acute
ischaemic stroke. Steering Committees of the ASK and MAST-E trials.
Australian Streptokinase Trial. Lancet 346:56, 1995.
Donnan,
G.A., Jones, E. Aortic arch atheroma and stroke risk. Cerebrovascular
Diseases 5:10-13, 1995.
Donnan,
G.A., You, R., Thrift, M., McNeil, J.J. Cholesterol as a risk factor
for stroke. Hypertension Research 17 Suppl 1:551-554, 1995.
1996
Davis,
S.M., Donnan, G.A. Acute Management of Stroke. Aust NZ J Med 26:11-14,
1996.
Donnan
GA, Davis SM, Chambers BR, et al. Streptokinase in acute ischaemic
stroke:does time of therapy administration affect outcome? JAMA 1996;
276: 961-966.
Donnan,
G.A. Posterior leukoencephalopathy syndrome. Lancet 347:988, 1996.
Donnan,
G.A., Davis, S.M. Thrombolytic therapy in acute ischaemic stroke:
Do the benefits outweigh the risks? CNS Drugs 6(4):257-262, 1996.
Donnan,
G.A., Davis, S.M., Chambers, B.R., Gates, P.C., Hankey, G.J., McNeil,
J.J., Rosen, D., Stewart-Wynne, E.G., Tuck, R.R. Streptokinase for
acute ischaemic stroke with relationship to time of administration.
JAMA 276:961-966, 1996.
Donnan,
G.A., O'Malley, H., Quang, L.C., Hurley, S. The Capsular Warning Syndrome:
The high risk of early stroke. Cerebrovasc Dis. 6:202-207, 1996.
1997
Davis,
S.M., Donnan, G.A. Thrombolysis for acute stroke. (Editorial) J. Clin.
Neurosci 4:1-2, 1997.
Donnan
GA, Dewey H, Davis SM, Thrift A. Acute brain infarction: early changes
in neurological status. Cerebrovascular Diseases 7(suppl 5):6-9, 1997.
Donnan,
G.A. Transient ischaemic attacks: Should they be investigated and
treated? Current Therapeutics 38:71-72, 1997.
Donnan,
G.A., Darby, D.G., Saling, M.M. Identification of brain region for
coordinating speech articulation. Lancet 349:221-222, 1997.
Donnan,
G.A., Dewey, H., Davis, S.M., Thrift, A. Acute brain infarction: early
changes in neurological status. Cerebrovascular Diseases 7:6-9, 1997.
1998
Davis,
S.M., Donnan, G.A. Secondary prevention for stroke after CAPRIE and
ESPS-2. Opinion 1. Cerebrovascular Disease 8:73-77, 1998.
Donnan
GA, Davis SM, Chambers BR, Gates PC. Surgery for prevention of stroke.
Lancet 1998; 351: 1372-3 (editorial).
Donnan,
G.A. Results from stroke trials are clarifying treatment efficacies.
Current Therapeutics 38:19(special report) Dec 1997/Jan 1998.
Donnan,
G.A., Davis, S.M., Chambers, B.R., Gates, P.C. Surgery for prevention
of stroke Lancet 351:1372-1373, 1998 (Commentary).
1999
Davis,
S.M., Donnan, G.A. Modern management of stroke. Mod Med Aust 42:36-43,
1999.
Dewey,
H.M., Donnan, G.A., Freeman, E.J., Sharples, C.M., Macdonell, R.A.L.,
McNeil, J.J., Thrift, A.G. Interrater reliability of the National
Institutes of Health Stroke Scale: Rating by neurologists and nurses
in a community-based stroke incidence study. Cerebrovascular Diseases
9:323-327, 1999.
Donnan,
G.A. The wide distribution of centers for swallowing. Invited Commentary
- Journal Watch Neurology 2(1):4, 1999.
Donnan,
G.A., Carey, L.M., Saling, M.M. More (or less) on Broca. Lancet 353:1031-1032,
1999.
Donnan,
G.A., Thrift, A.G., Davis, S.M. Blood pressure lowering and stroke.
PROGRESS On Line (Servier) 1999.
2000
Davis,
S.M., Tress, B., Barber, P.A., Darby, D., Parsons, M., Gerraty, R.,
Yang, Q., Li, T., Donnan, G.A. Echoplanar matgnetic resonance imaging
in acute stroke. Journal of Clinical Neuroscience 7:3-8, 2000.
Donnan,
G.A. Unruptured aneurysms should generally be clipped. Invited Commentary
Journal of Clinical Neurosciences 7(4):348, 2000.
Donnan,
G.A., Davis, S.M. Neurology: reflections on the past millenium as
we enter the next. J. Clin Neurosci 7:1-2, 2000.
2001
Davis,
S.M., Donnan, G.A. Neuroprotection: Establishing proof of concept
in human stroke. Stroke (Controversies) 33:309-310, 2001.
Davis,
S.M., Donnan, G.A. Thrombolysis for stroke: Defining the time window.
When is Enough Enough? Invited Editorial. Stroke (Controversies) 32:2710-2711,
2001.
Davis,
S.M., Donnan, G.D. Newer antiplatelet therapies in stroke prevention.
Australian Family Physician 30:129-134, 2001.
Dewey
HM, Macdonell RAL, Donnan GA, McNeil JJ, Freeman EJ, Thrift AG, Sharples
CM. Inter-rater reliability of stroke sub-type classification by neurologists
and nurses within a community-based stroke incidence study. J Clin
Neurosciences 8(1):14-17, 2001.
Dewey,
H.M., Thrift, A.G., Mihalopoulos, C., Carter, R., Macdonell, R.A.L.,
McNeil, J.J., Donnan, G.A. Cost of stroke in Australia from a societal
perspective: Results from the North East Melbourne Stroke Incidence
Study (NEMESIS). Stroke 32:2409-2416, 2001.
Donnan,
G.A. Clinical role of cerebrovascular imaging (Editorial). Australian
Prescriber 24:134, 2001.
Donnan,
G.A. Corticosteroids do not improve visual acuity in acute monosymptomatic
optic neuritis over the long term (Commentary). ACP Journal Club 131:12,
2001.
Donnan,
G.A. Gemfibrozil reduced the risk for stroke in men with coronary
heart disease and low levels of HDL cholesterol. (Commentary) ACP
Journal Club135:86, 2001.
Donnan,
G.A., Davis, S.M. Thrombolysis in acute ischaemic stroke (invited
review). J of Clin Neurosci 8:112-115, 2001.
2002
Dewey,
H.M., Thrift, A.G., Mihalopoulos, C., Carter, R., Macdonell, R.A.L.,
McNeil, J.J., Donnan, G.A. Informal care for stroke survivors: results
from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke
33:1028-1033, 2002.
Donnan
GA, Dewey HM, Thrift AG. Epidemiology of stroke in western countries.
Medicographia 72(24):93-97, 2002.
Donnan,
G.A. Commentary on J.M. Wardlaw article – Review: thrombolysis
increases short term death and intracranial haemorrhage but decreases
long term death or dependence. Evidence Based Medicine 7:48, 2002.
Donnan,
G.A., Davis, S.M. Aspirin therapy should be first line: Probably,
but watch this space. Stroke (Controversies) 33:2139-2140, 2002.
Donnan,
G.A., Dewey, H.M., Thrift, A.G. Epidemiology of stroke in western
countries. Medicographia Issue 72:24:93-97- 2002.
2003
Davis SM, Donnan GA. CT Screening for Thrombolysis:
Uncertainties Remain. Stroke 34:822-823, 2003.
Davis, S.M., Donnan, G.A. Blood pressure reduction
and ACE inhibition in secondary stroke prevention:
mechanism uncertain. Stroke 34:1335-1336, 2003.
Davis, S.M., Donnan, G.A. Is Carotid Angiography
Necessary? Editors Disagree. Stroke 34:1819, 2003.
Dewey
HM, Sturm J, Donnan GA, Macdonell RAL, McNeil JJ, Thrift AG. Incidence
and outcome of subtypes of ischaemic stroke: initial results from
the North East Melbourne Stroke Incidece Study (NEMESIS). Cerebrovascular
Diseases 15:133-9, 2003.
Dewey, H. M., Thrift, A. G., Mihalopoulos, C., Carter, R.,
Macdonell, R. A., McNeil, J. J., Donnan, G.A. Lifetime
cost of stroke subtypes in Australia: findings from the
North East Melbourne Stroke Incidence Study
(NEMESIS). Stroke 34:2502-2507, 2003.
Donnan, G.A., Davis, S.M., Jones, E.F., Amarenco, P.
Aortic source of brain embolism. Curr Treat Options
Cardiovasc Med 5:211-219, 2003.
Donnan, G.A., Davis, S.M. Surgery for intracerebral
hemorrhage: an evidence-poor zone. Stroke 34:1569-
1570, 2003.
Donnan, G.A., Davis, S.M., Kaste, M. Recommendations
for the relationship between sponsors and
investigators in the design and conduct of clinical
stroke trials. Stroke 34:1041-1045, 2003.
Donnan, G. A. What are the mechanisms of stroke?
Dialogues in Cardiovascular Medicine 8(1):15-21, 2003.
Donnan, G.A., Davis, S.M. Controversy: the essence of
medical debate. Stroke 34:372-373, 2003.
Donnan, G.A., Davis, S.M. Heparin in stroke: not for
most, but the controversy lingers. Stroke 34:232-233,
2003.
Donnan
GA, Davis SM, Thrift AG. The role of blood pressure lowering before
and after stroke. Current Opinion in Neurology 16:81-86, 2003.
Donnan, G.A., Davis, S.M. Levi, C.R. Strategies to
improve outcomes after acute stroke. MJA 178:309-
310, 2003.
Donnan, G.A. PROGRESS Results: Implementation in
Stroke Guidelines. J Hypertens Suppl 21 Suppl 5:S25-
28, 2003.
Donnan, G.A., Davis, S.M. Neuroimaging, The Ischaemic
Penumbra and selection of patients for acute stroke
therapy. Lancet Neurology 1:417-425, 2003.
Donnan, G.A., Howells, D.W., Markus, R., Toni, D., Davis,
S.M. Can the tine window for administration of
thrombolytics in stroke be increased? CNS Drugs
17:995-1011, 2003.
Duffy, B.K., Phillips, P.A., Davis, S.M., Donnan, G.A.,
Vedadhaghi, M.E. Evidence-based care and outcomes
of acute stroke managed in hospital specialty units.
Med J Aust 178:318-323, 2003.
2004
Davis SM, Donnan GA: Steroids for stroke: another potential therapy discarded prematurely? Stroke 35(1): 230-231, 2004.
Davis SM, Donnan GA: Advances in penumbra imaging with MR. Cerebrovasc Dis 17 Suppl 3: 23-27, 2004.
Davis SM, Donnan GA: Effective prophylaxis for deep venous thrombosis after stroke: both low-dose anticoagulation and stockings for most cases. Stroke 35(12): 2910, 2004.
Davis SM, Donnan GA: Why lacunar syndromes are different and important. Stroke 35(7): 1780-1781, 2004.
Davis SM, Donnan GA: Stroke unit design: high tech versus low tech. Stroke 35(4): 1021, 2004.
Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RA, McNeil JJ, Donnan GA: 'Out of pocket' costs to stroke patients during the first year after stroke - results from the North East Melbourne Stroke Incidence Study. J Clin Neurosci 11(2): 134-137, 2004.
Donnan GA: Stroke: prediction, prevention, and outcome. Lancet Neurol 3(1): 9, 2004.
Donnan GA, Davis SM: Patent foramen ovale and stroke: closure by further randomized trial is required! Stroke 35(3): 806, 2004.
Donnan GA, Davis SM: Stroke and cholesterol: weakness of risk versus strength of therapy. Stroke 35(6): 1526, 2004.
Donnan GA, Dewey HM, Chambers BR: Warfarin for atrial fibrillation: the end of an era? Lancet Neurol 3(5): 305-308, 2004.
2005
Davis SM, Donnan GA: Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation. Stroke 36(5): 1106-1107, 2005.
Davis SM, Donnan GA, Butcher KS, Parsons M: Selection of thrombolytic therapy beyond 3 h using magnetic resonance imaging. Curr Opin Neurol 18(1): 47-52, 2005.
Donnan GA, Davis SM: Stroke drug development: usually, but not always, animal models. Stroke 36(10): 2326, 2005.
Donnan GA, Davis SM: Patients with small, asymptomatic, unruptured intracranial aneurysms and no history of subarachnoid hemorrhage should be treated conservatively. Stroke 36(2): 407, 2005.
Donnan GA, Davis SM: Extracranial arterial dissection: anticoagulation is the treatment of choice. Stroke 36(9): 2043-2044, 2005.
Donnan GA, Dewey HM: Stroke and nutrition: FOOD for thought. Lancet 365(9461): 729-730, 2005.
Donnan GA, Ly JV: Should ximelagatran replace warfarin for stroke prevention in patients with atrial fibrillation? Nat Clin Pract Cardiovasc Med 2(6): 278-279, 2005.
Donnan GA, Plummer C, Rattray K, Basilli S: An unusual disease presenting at an unusual age: Susac's syndrome. J Clin Neurosci 12(1): 99, 2005.
2006
Davis S, Lees K, Donnan G: Treating the acute stroke patient as an emergency: current practices and future opportunities. Int J Clin Pract 60(4): 399-407, 2006.
Davis SM, Donnan GA: The stroke-prone state: rapid assessment of transient ischemic attacks. Stroke 37(4): 1140, 2006.
Davis SM, Donnan GA: Immediate anticoagulation for acute stroke in atrial fibrillation: no, but. Stroke 37(12): 3056, 2006.
Davis SM, Donnan GA: Basilar artery thrombosis: recanalization is the key. Stroke 37(9): 2440, 2006.
Davis SM, Donnan GA: Merci Retriever: Does it Work? Stroke 37(5): 1343-1344, 2006.
Donnan GA, Davis SM, Hill MD, Gladstone DJ: Patients with transient ischemic attack or minor stroke should be admitted to hospital: for. Stroke 37(4): 1137-1138, 2006.
Donnan GA, Dewy HM, Thrift AG, Sturm JW: The epidemiology of stroke. Stroke: Selected topics. Seminars in Clinical Neurology 4, 2006.
Donnan GA, Ly J: Aspirin after intracerebral haemorrhage: probably safer than we thought. Lancet Neurol 5(4): 288-289, 2006.
2007
Dewey H, Sherry L, Collier J: Stroke Rehabilitation 2007 - what should it be? International Journal of Stroke 2(3): 191-200, 2007.
Dewey HM, Bernhardt J: Acute stroke patients--early hospital management. Aust Fam Physician 36(11): 904-912, 2007.
Donnan GA: From clinical trial to clinical practice. Neurol India 55(2): 102-103, 2007.
Donnan GA, Davis SM: Stenting for middle cerebral artery stenosis: inevitable but when and how. Stroke 38(4): 1422, 2007.
Donnan GA, Dewey HM, Davis SM: MRI and stroke: why has it taken so long? Lancet 369(9558): 252-254, 2007.
Donnan GA, Levi C: Glucose and the ischaemic brain: too much of a good thing? Lancet Neurol 6(5): 380-381, 2007.
E
1982
Ell JJ, Gresty MA, Chambers BR, Findley LJ. Acquired pendular nystagmus:
characteristics, pathophysiology and pharmacological modification.
In "Physiological and Pathological Aspects of Eye Movements".
1982.
2003
European/Australasian Stroke Prevention in Reversible
Ischaemia Trial (ESPRIT) Study Group. Oral
anticoagulation in patients after cerebral ischemia of
arterial origin and risk of intracranial hemorrhage.
Stroke 34:e45-347, 2003.
2004
Ekinci EI, Donnan GA: Neurological manifestations of cardiac myxoma: a review of the literature and report of cases. Intern Med J 34(5): 243-249, 2004.
F
1983
Fisher
A, Gresty MA, Chambers BR, Rudge P. Primary position upbeating nystagmus:
a variety of central positional nystagmus. Brain 1983; 106: 949-964.
1988
Freilich
RJ, Chambers BR. Choreoathetosis and thalamic haemorrhage. Clin Exp
Neurol 1988; 25: 115-20.
1991
Forrest
S.M., H-H. Dahl, D.W. Howells, I. Dianzani, R.G.H. Cotton. Mutation
detection in phenylketonuria using the chemical cleavage of mismatch
method: importance of using probes from both normal and patient samples.
Am. J. Hum. Genet. 1991. 49: 175-183.
1993
Farrar, J., Donnan, G.A. Capsular Warning Syndrome Preceding Pontine
Infarction. Stroke, 24:762, 1993.
Fitt,
G.J., Farrar, J., Baird, A.E., Brooks, M., Gilligan, A., Donnan, G.A.,
Hennessy, O. Intra-arterial streptokinase in acute ischaemic stroke.
Med. J. Aust. 159:331-334, 1993.
1999
Friend
KL, Crimmins D, Phan TG, Sue CS, Colley A, Fung VSC, Morris JGL, Sutherland
GR, Richards RI. Detection of a novel missense mutation and second
recurrent mutation in the CACNA1A gene in individuals with EA-2 and
FHM. Human Genetics 1999; 105: 261-265.
2003
Fedi, M., Reutens, D.C., Andermann, F., Okazawa, H.,
Boling, W., White, C., Dubeau, F., Nakai, A., Gross, D.W.,
Andermann, E., Diksic, M. alpha-[11C]-Methyl-
Ltryptophan PET identifies the epileptogenic tuber and
correlates with interictal spike frequency. Epilepsy Res
52:203-13, 2003.
2004
Falcao AL, Reutens DC, Markus R, Koga M, Read SJ, Tochon-Danguy H, Sachinidis J, Howells DW, Donnan GA: The resistance to ischemia of white and gray matter after stroke. Ann Neurol 56(5): 695-701, 2004.
2005
Fisher M, Albers GW, Donnan GA, Furlan AJ, Grotta JC, Kidwell CS, Sacco RL, Wechsler LR: Enhancing the development and approval of acute stroke therapies: stroke therapy academic industry roundtable. Stroke 36(8): 1808-1813, 2005.
G
1991
Goadsby,
P.J., Zagami, A.S., Donnan, G.A., Symington, G., Anthony, M., Bladin,
P.F., Lance, J.W. Oral sumatriptan in acute migraine. Lancet, 338:782-783,
1991.
1994
Giles, G.G. McNeill, J.J. Donnan, G.A. Wesley, C., Staples, M.P.,
Ireland, P.D., Hurley, S.F., Salzburg, M. Dietary factors and the
risk of glirina in adults: results of a case control study in Melbourne,
Australia. Int. J. Cancer. 59:357-362, 1994.
2002
Gilligan,
A.G., Markus, R., Read, S.J., Srikanth, V., Hirano, T., Fitt, G.,
Arends, M., Chambers, B.R., Davis, S.M., Donnan, G.A. Baseline blood
pressure and not early CT changes predict major hemorrhage after streptokinase
in acute ischemic stroke. Stroke 33:2236-2242, 2002.
2004
Guadagno JV, Donnan GA, Markus R, Gillard JH, Baron JC: Imaging the ischaemic penumbra. Curr Opin Neurol 17(1): 61-67, 2004.
2005
Gilligan AK, Thrift AG, Sturm JW, Dewey HM, Macdonell RA, Donnan GA: Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit? Cerebrovasc Dis 20(4): 239-244, 2005.
2006
Gates PC, Chambers B, Yan B, Chong W, Denton M: Symptomatic and asymptomatic carotid stenosis: just when we thought we had all the answers. Intern Med J 36(7): 445-451, 2006.
Griffin A, Bernhardt J: Strapping the hemiplegic shoulder prevents development of pain during rehabilitation: a randomized controlled trial. Clin Rehabil 20(4): 287-295, 2006.
H
1982
Hamdy
R.C., I.R.F. Brown, D.W. Howells, J.A. Nisbet. Vitamin A and Paget's
disease. Lancet 1982: 2, 1103.
1983
Howells
D.W., I.R.F. Brown, O.G. Brooke, V. Newey. A simple automated injection
technique for the high-pressure liquid chromatographic determination
of plasma retinol. Ann. Clin. Biochem. 1983: 20, 308-311.
1984
Howells
D.W., G.E. Levin, I.R.F. Brown, O.G. Brooke. Plasma retinol and retinol-binding
protein in pre-term infants born small for gestational age or of appropriate
weight for age. Human Nutrition: Clinical Nutrition. 1984: 38, 107-111.
1986
Howells
D.W., F. Haste, D. Rosenberg, I.R.F. Brown, O.G. Brooke. Investigation
of vitamin A nutrition in pregnant British Asians and their infants.
Human Nutrition: Clinical Nutrition 1986: 40c, 43-50.
Howells
D.W., I. Smith, J. Leonard, K. Hyland. Tetrahydrobiopterin in diyhdropteridine
reductase deficiency. New England Journal of Medicine 1986: 314, 520.
Howells
D.W., I. Smith, K. Hyland. Estimation of tetrahydrobiopterin and other
pterins in cerebrospinal fluid using reverse-phase high-performance
liquid chromatography. J. Chromatography 1986: 381, 35-41.
1987
Howells
D.W., I.Smith, K. Hyland. Dihydroneopterin and CNS infections. Lancet.
1987: 2, 686.
Howells
D.W., K. Hyland. Direct analysis of tetrahydrobiopterin in cerebrospinal
fluid by high-performance liquid chromatography with REDOX electrochemistry:
Prevention of autoxidation during storage and analysis. Clinica Chimica
Acta. 1987: 167, 23-30.
1988
Hyland
K., D.W. Howells. Analysis and clinical significance of pterins. J.
Chromatography 1988: 429, 95-121.
1989
Habibi P., S.Strobel, I. Smith, K. Hyland, D.W. Howells, H. Holzel,
E.M. Brett, J. Wilson, G. Morgan, R.J. Levinsky. Neurodevelopmental
delay and focal seizures as presenting symptoms of human immunodeficiency
virus infection. Eur. J. Pediatr. 1989. 148: 315-317.
1990
Howells
D.W., S. Strobel, I. Smith, R.J. Levinsky, K. Hyland. Central nervous
system involvement in the erythrophagocytic disorders of infancy:
The role of cerebrospinal fluid neopterins in their differential diagnosis
and clinical management. Pediatric Research.1990: 28, 116-119
Howells
D.W., S.M. Forrest, H.-H M. Dahl, R.G.H. Cotton. Insertion of an extra
codon for threonine is a cause of dihydropteridine reductase deficiency.
Am. J. Hum. Genet. 1990. 47: 279-285.
1992
Howells
D.W., C. Jakobs, R. Kok, J. Wrennall, G.N. Thompson. Vigabatrin therapy
in succinic semialdehyde dehydrogenase deficiency. Mol. Neuropharm.
1992. 2: 181-184.
Howells
D.W., K. Hyland, I. Smith, S. Strobel. Tryptophan and serotonin metabolism
in familial erythrophagocytic lymphohistiocytosis. J. Inher. Metab.
Dis. 1992 15: 891-897.
1993
Howells,
D.W., Donnan, G.A., Wong, J.F., Kaczmarczyk, S.J., Chilcho, P.T.,
Fabinyi, G.A., Mendelsohn, F.A.O. Surgical damage stimulates proliferation
of dopamine uptake sites in normal mouse brain. Brain Res. 622:285-288,
1993.
Hyland
K., R.A.H. Surtees, S.J.R. Heales, A. Bowron, D.W. Howells, I. Smith.
Cerebrospinal fluid concentrations of pterins and metabolites of serotonin
and dopamine in a pediatric reference population. Pediatric Research
1993 34: 10-14.
1995
Howells,
D.W,. Wong, J.Y.F,. Churchyard, A.J,. Donnan, G.A., Leukaemia inhibitory
factor prevents proliferation of dopamine uptake sites caused by surgical
damage to normal mouse striatum. Neuroreport. 16;14:1857-1860, 1995.
1996
Hill
K, Bernhardt J, McGann A, Maltese D and Berkovits D. A new test of
dynamic standing balance for stroke patients: Reliability, validity
and comparison with healthy elderly. Physiotherapy Canada 48(4); 257-262,
1996.
Howells,
D.W., Wong, J.Y.F,. Liberatore, G.T,. Donnan, G.A,. Dopaminergic responses
to striatal damage. Journal of the Neurological Sciences 139:125-130,
1996.
Hurley,
S.F., McNeil, J.J., Donnan, G.A., Forbes, A., Salzberg, M., Giles,
G.G. Tobacco smoking and alcohol consumption as risk factors for glioma:
a case-control study in Melbourne, Australia. J Epidemiol Community
Health 50:442-446, 1996.
1997
Hill
K, Ellis P, Bernhardt J, Maggs T, Hull S. Balance and mobility outcomes
for stroke patients: A comprehensive audit. Australian Journal of
Physiotherapy 43(3); 173-180, 1997.
1998
Hacke,
W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D.,
Larrue, V., Bluhmki, E., Davis, S., Donnan, G.A., Schneider, D., Diez-Tejedor,
E., Trouillas, P., for the Second European-Australasian Acute Stroke
Study Investigators. Randomised double-blind placebo-controlled trial
of thrombolytic therapy with intravenous alteplase in acute ischaemic
stroke (ECASS II). European Cooperative Acute Stroke Study II. Lancet
352:1245-1251, 1998.
1999
Hacke,
W., Brott, T., Caplan, L., Meier, D., Fieschi, C., von Kummer, R.,
Donnan, G.A., Heiss, W.D., Wahlgren, N.G., Spranger, M., Boysen, G.,
Marler, J.R. Thrombolysis in Acute Ischemic Stroke: Controlled Trials
and Clinical Experience. Neurology 53(Supp 4):S3-S14, 1999.
Hirano
T, Read SJ, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, Egan
GF, Scott AM, Bladin CF, McKay WJ, Donnan GA. No evidence of hypoxic
tissue surrounding intracerebral haemorrhage using PET and 18F-fluoromisonidazole.
Neurology 53:2179-2182, 1999.
2000
Howells,
D.W., Porritt, M.J., Wong, J.Y.F., Batchelor, P.E., Kalnins, R., Hughes,
A.J., Donnan, G.A. Reduced BDNF mRNA expression in the Parkinson’s
disease substantia nigra. Experimental Neurology 166:127-135, 2000.
2001
Henderson
RD, Phan TG, Piepgras DG, Wijdicks EFM. Mechanisms of cerebral hemorrhage
after carotid endarterectomy. J Neurosurg. 2001; 95: 964-969.
Hirano,
T., Read, S.J., Abbott, D.F., Baird, A.E., Yasaka, M., Infeld, B.,
Barber, P.A., Davis, S.M., McKay, W.J., Donnan, G.A. Prediction of
the final infarct volume within 6 hours of stroke using single photon
emission computed tomography with technetium-99m hexamethylpropylene
amine oxime. Cerebrovascular Diseases 11:119-127, 2001.
2004
Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Jr., Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363(9411): 768-774, 2004.
2005
Ho PW, Reutens DC, Phan TG, Wright PM, Markus R, Indra I, Young D, Donnan GA: Is white matter involved in patients entered into typical trials of neuroprotection? Stroke 36(12): 2742-2744, 2005.
Horn J, Naylor AR, Laman DM, Chambers BR, Stork JL, Schroeder TV, Nielsen MY, Dunne VG, Ackerstaff RG: Identification of patients at risk for ischaemic cerebral complications after carotid endarterectomy with TCD monitoring. Eur J Vasc Endovasc Surg 30(3): 270-274, 2005.
2007
Hamidon BB, Dewey HM: Impact of acute stroke team emergency calls on in-hospital delays in acute stroke care. J Clin Neurosci 14(9): 831-834, 2007.
Hoare, B., Imms, C., and Carey, L. Wasiak J. Constraint induced movement therapy in the treatment of the upper limb in children with spastic hemiplegic cerebral palsy: a Cochrane systematic review. Clinical Rehabilitation 21:675-685. [IF = 1.5], 2007.
Hoare, B., Wasiak J. Imms, C., and Carey, L.Constraint induced movement therapy in the treatment of the upper limb in children with spastic hemiplegic cerebral palsy (Cochrane Review). The Cochrane Library, Issue 2. Chichester, UK: John Wiley & Sons, Ltd., 2007.
Hoare BJ, Wasiak J, Imms C, Carey L: Constraint induced movement therapy in the treatment of upper limb in children with spastic hemiplegic cerebral palsy (Cochrane Review). in The Cochrane Library Chichester, UK, John Wiley& Sons, Ltd, 2007.
Ibuki A, Bernhardt J: What is spasticity? The discussion continues. International Journal of Therapy and Rehabilitation 14(9): 391-395, 2007.
I
1996
Infeld, B., Davis, S.M., Donnan, G.A., Lichtenstein, M., Baird, A.E.,
Binns, D., Mitchell, P.J., Hopper, J.L. Streptokinase increases luxury
perfusion after stroke. Stroke 27:1524-1529, 1996.
1999
Infeld,
B., Davis, S.M., Donnan, G.A., Yasaka, M., Lichtenstein, M., Mitchell,
P.J., Fitt, G.J. Nimodipine and perfusion changes after stroke. Stroke
30:1417-1423, 1999.
2003
International Society of Hypertension Writing Group.
International Society of Hypertension (ISH): statement
on blood pressure lowering and stroke prevention. J
Hypertens 21:651-63, 2003.
J
1993
Jones,
E.F., Donnan, G.A., Calafiore, P., Tonkin, A.M. Transoesophageal echocardiography
in the investigation of stroke: Experience in 135 patients with cerebral
ischaemic events. Aust. N.Z. J. Med. 23:477-483, 1993.
1994
Jones,
E., Calaforie, P., Donnan, G.A., Tonkin, A.M. Evidence that patent
foramen ovale is not a risk factor for cerebral ischemia in the elderly.
Am. J. Cardiol. 74: 596-599, 1994.
1995
Jenkins
T A , S.Y. Chai, D.W. Howells, FAO. Mendelsohn. Intrastriatal angiotensin
II induces turning behaviour in 6-hydroxydopamine lesioned rats. Brain
Research 1995; 691: 213-216.
Jones,
E.F., Donnan, G.A. The proximal aorta: a source of stroke. Baillieres
Clin Neurol 4:207-220, 1995. (Review).
Jones,
E.F., Kalman, J.K., Calafiore, P., Tonkin, A.M., Donnan, G.A. Proximal
Aortic Atheroma. Stroke, 26:218-224, 1995.
1996
Jones,
E.F., Calafiore, P., McNeil, J.J., Tonkin, A.M., Donnan, G.A. Atrial
fibrillation with left atrial spontaneous contrast detected by transesophageal
echocardiography is a potent risk factor for stroke. Am. J. Cardiol.
78:425-429, 1996.
1999
Jackson
GD, Chambers BR, Berkovic SF. Hippocampal sclerosis: development in
adult life. Dev Neurosci 1999; 21: 207-14.
Jenkins
TA., JYF. Wong, DW. Howells, FAO. Mendelsohn, SY. Chai. Effect of
chronic angiotensin converting enzyme inhibition on striatal dopamine
content in the MPTP-treated mouse. J. Neurochemistry 1999; 73: 214-9.
K
1993
Kent
P, Hill K and Bernhardt J. Functional prediction post stroke. Australian
Journal of Physiotherapy 39: 281-289, 1993.
Kent
P, Keating J, Bernhardt J et al. Evidence based practice. Leading
article. Australian Journal of Physiotherapy 45; 167-171, 1999.
Kok
R.M., D.W. Howells, C.C.M. van de Heuvel, W.S Guerand, G.N. Thompson,
C. Jakobs. Stable isotope dilution analysis of Gaba in CSF using simple
solvent extraction and electron capture negative ion mass fragmentography.
J. Inher. Metab. Dis. 1993 16: 508-512.
1999
Kalarostaghi A, Pell M, Turner J, Markus R, Coffey G. Polymicrobial
brain stem abscess due to Streptococcus anginosus and Actinomyces
species. Journal of Clinical Neuroscience 1999; 6(5): 416-417.
2000
Kazui,
S., Levi, C.R., Jones, E.F., Quang, L., Calafiore, P., Donnan, G.A.
Risk factors for lacunar stroke: A case-control transophageal echocardiographic
study. Neurology 54:1385-1387, 2000.
Koh
M, Phan TG, Atkinson JLD, Wijdicks EFM. The role of neuroimaging in
the management of cerebellar infarct with mass effect. Stroke 2000:
31; 2062-2067.
Koh M, Phan TG, Wijdicks EFM. The surgical management of cerebellar
infarct with mass effect. The Neurologist May 2000.
2001
Kazui,
S., Levi, C.R., Jones, E.F., Quang, L., Calafiore, P., Donnan, G.A.
Lacunar stroke: Transoesophageal echocardiographic factors influencing
long-term prognosis. Cerebrovasc Dis 12:325-330, 2001.
2003
Koga, M., Saku, Y., Toyoda, K., Takaba, H., Ibayashi, S.,
Iida, M. Reappraisal of early CT signs to predict the
arterial occlusion site in acute embolic stroke. J
Neurol Neurosurg Psychiatry 74:649-53, 2003.
Krams, M., Lees, K.R., Hacke, W., Grieve, A.P., Orgogozo,
J.M., Ford, G.A., for the ASTIN Study Investigators. Acute
Stroke Therapy by Inhibition of Neutrophils (ASTIN): An
adaptive dose-response study of UK-279,276 in acute
ischemic stroke. Stroke 34:2543-2548, 2003.
2004
Kimura K, Stork JL, Levi CR, Abbott AL, Donnan GA, Chambers BR: High intensity transient signals in patients with carotid stenosis may persist after carotid endarterectomy. Cerebrovasc Dis 17(2-3): 123-127, 2004.
2005
Koga M, Reutens DC, Wright P, Phan T, Markus R, Pedreira B, Fitt G, Lim I, Donnan GA: The existence and evolution of diffusion-perfusion mismatched tissue in white and gray matter after acute stroke. Stroke 36(10): 2132-2137, 2005.
L
1979
Lander, C.M., Donnan, G.A., Bladin, P.F., Vajda, F.J.E. Some aspects
of the clinical use of clonazepam in refractory epilepsy. Clin. Exp.
Neurol., 16:325-332, 1979.
1996
Levi,
C.R., Mitchell, A., Fitt, G., Donnan, G.A. The accuracy of magnetic
resonance angiography in the assessment of extracranial carotid artery
occlusive disease. Cerebrovasc Dis 6:231-236, 1996.
1997
Levi,
C.R., Bladin, C.F., Chambers, B.C., Royle, J.P., Donnan, G.A. Microembolic
watershed infarction complicating carotid endarterectomy. Cerebrovascular
Diseases 7:185-186, 1997.
Levi,
C.R., O’Malley, H.M., Fell, G., Roberts, A.K., Hoare, M.C., Royle,
J.P., Chan, A., Beiles, B.C., Chambers, B.R., Bladin, C.F., Donnan,
G.A. Transcranial Doppler detected cerebral microembolism following
carotid endarterectomy: high microembolic signal loads predict postoperative
cerebral ischaemia Brain 120:621-629, 1997.
Levi,
C.R., Roberts, A.K., Fell, G., Hoare, M.C., Royle, J.P., Chan, A.,
Beiles, B.C., Last, G.C., Bladin, C.F. Donnan, G.A. Transcranial Doppler
embolus detection during and following carotid endarterectomy: application
to the identification of high perioperative stroke risk patients.
European Journal of Vascular and Endovascular Surgery 14(3):170-176,
1997.
Liberatore,
G.T., Wong, J.Y.F., Porritt, M.J., Donnan, G.A., Howells, D.W. Expression
of glial cell line-derived neurotrophic factor (GDNF) mRNA following
mechanical injury to mouse striatum. NeuroReport 8:3097-3101, 1997.
1998
Levi,
C.R., Read, S.J., Teruyuki, H., Donnan, G.A. Extensive hemispheric
cerebral infarction. Journal of Stroke & Cerebrovascular Diseases
7(6):398-403, 1998.
Levi,
C.R., Stork, J.L., Chambers, B.R., Abbott, A.L., Cameron, H., Peeters,
A., Royle, J.P., Roberts, A.K., Fell, G., Hoare, M.C., Chan, A.T.,
Donnan, G.A. Dextran reduces embolic signals after carotid endarterectomy.
Ann Neurol 50(4):544-7, 2001.
1999
Liberatore
GT., JYF. Wong, D. Krenus, BJ. Jeffreys, MJ. Porritt, DW. Howells.
Tissue fixation is the key to preventing contamination of tritium
sensitive storage phosphor imaging plates. Biotechniques 1999; 26:
432-433.
Liberatore,
G.T., Finkelstein, D.I., Wong, J.Y.F., Horne, M.K., Porritt, M.J.,
Donnan, G.A., Howells, D.W. Sprouting of dopaminergic axons after
striatal injury: Confirmation by markers not dependent on dopamine
metabolism. Experimental Neurology 159:565-573, 1999.
2001
Levi
CR, Selmes C, Chambers BR. Transcranial ultrasound – clinical
applications in cerebral ischaemia. Aust Prescr 2001;24:137-40.
Levi
CR, Stork JL, Chambers BR, et al. Dextran reduces embolic signals
after carotid endarterectomy. Ann Neurol 2001 Oct;50(4):544-7.
2002
Langhorne P, Cadilhac D, Feigin V, Grieve R, Liu M: How should stroke services be organised? Lancet Neurol 2002, 1(1):62-68.
2003
Liberatore, G.T., Samson, A., Schleuning, W-D., Bladin,
C., Medcalf, R.L. Unlike tissue-type plasminogen
activator, Desmodus rotundus (vampire bat) salivary
plasminogen activator does not promote
neurodegeneration. Stroke 34: 537-543, 2003.
2005
Ly JV, Donnan GA: Review: Early supported discharge reduces death or dependence after stroke. ACP J Club 143(2): 30, 2005.
2006
Ly JV, Zavala JA, Donnan GA: Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke. Expert Opin Pharmacother 7(12): 1571-1581, 2006.
2007
Lim AK, Donnan G, Chambers B, Ierino FL: Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity. Intern Med J 37(1): 55-59, 2007.
M
1986
Macdonell,
R.A.L., Kalnins R.M., Donnan G.A. Non-bacterial thrombotic endocarditis
and stroke. Clin. Exp. Neurol., 22:123-132, 1986.
1987
Mathers
SE, Chambers BR, Merory JR, Alexander I. Subcortical arteriosclerotic
encephalopathy: Binswanger’s disease. Clin Exp Neurol 1987; 23:
67-70.
1987
Macdonell,
R.A.L., Donnan, G.A., Kalnins, R.M. Cerebellar Infarction: Natural
History Prognosis and Pathology. Stroke, 18:849-855, 1987.
Macdonell,
R.A.L., Donnan, G.A., Kalnins, R.M., Richards, M.J., Bladin, P.F.
Otocerebral mucormycosis. Clin. Exp. Neurol., 23:225-231, 1987.
1988
Macdonell,
R.A.L., Donnan, G.A., Bladin, P.F., Berkovic, S.F., Wreidt, C.H.R.
The electroencephalogram and acute ischemic stroke: distinguishing
cortical from lacunar infarction. Arch. Neurol., 45:520-526, 1988.
1989
Macdonnel,
R.A.L., Donnan, G.A., Bladin, P.F. A Comparison of Motor and Sensory
Evoked Potentials in Stroke. Ann. Neurol., 25:68-73, 1989.
1991
Macdonell,
R.A,L., Donnan, G.A., Bladin, P.F. Serial changes in somatosensory
evoked potentials following cerebral infarction. Electroenceph. Clin.
Neurophysiol., 80:276-283, 1991.
Mendelsohn,
F.A.O., Donnan, G.A. Mapping the chemistry of the brain. SEARCH, 22:169-171,
1991.
1993
MacPhee
G.B., R.W. Logan, J.S. Mitchell, D.W. Howells, E. Tsotsis, D.R. Thorburn.
Malonyl coenzyme A decarboxylase deficiency. J. Inher. Metab. Dis.
1993 69: 433-436.
1995
Macdonell,
R.A.L., Donnan, G.A. Magnetic cortical stimulation in acute spinal
cord injury. Neurology 45:303-306, 1995.
1997
Markus
R, Turner J, Pell M, Brew B J. Successful outcome with aggressive
treatment of acute haemorrhagic leucoencephalitis. Journal of Neurology,
Neurosurgery and Psychiatry, 1997;63(4):551.
Mitchell,
P.J., Gerraty, R.P., Donnan, G.A., Fitt, G., Tress, B.M., Thomson,
K.R., Davis, S.M. for the AUST study group. Thrombolysis in the vertebrobasilar
circulation - The Australian Urokinase Stroke Trial (AUST) Pilot Study.
Cerebrovasc. Dis 7:94-99, 1997.
1998
Markus
R, Brew B J. HIV-1 peripheral neuropathy and combination antiretroviral
therapy: Lancet 1998;352:1906-7.
1999
Macdonell, R., Jackson, G., Curatolo, J., Abbott, D., Berkovic, S.,
Carey, L., Syngeniotis, A., Fabinyi, G., & Scheffer, I. (1999)
Motor cortex localisation using fMRI and transcranial magnetic stimulation.
Neurology, 53: 1462-1467.
Markus,
R., Kazui, S., Donnan, G.A. Antiplatelet Therapy in Stroke Patients
(invited review). Rev Soc Cardiol Estado de S?o Paulo 4: 606-612,
1999.
2002
Markus,
R., Donnan, G.A., Kazui, S., Read, S.J., Hirano, T., Scott, A.M.,
O’Keefe, G.J., Tochon-Danguy, H.J., Sachinidis, J.I., Reutens,
D.C. Statistical parametric mapping of hypoxic tissue identified by
18F-fluromisonidazole (18FMISO) and positron emission tomography (PET)
following acute ischaemic stroke. NeuroImage 16:425-433, 2002.
Markus,
R., Donnan, G.A., Kazui, S., Read, S.J., Reutens, D.C. Mapping the
spatial topography of the ischaemic penumbra in humans: The Penumbragram.
(submitted - Feb 2002).
2003
Ma, H., Donnan, G.A. TIA and stroke: A management
guide for GPs. Modern Medicine 4:16-27, 2003.
Macleod, M., Johansson, I-M., Söderström, I., Lai, M.,
Gidö, G., Wieloch, T., Seckl, J.R., Olsson, T.
Mineralocorticoid receptor expression and increased
survival following neuronal injury; a new therapeutic
target in cerebral ischaemia. European Journal of
Neuroscience, 17, 1549-1555. 2003.
Macleod, M.R., Donnan, G.A. (2003) Atheroma of the
aortic arch: the missing link in the secondary
prevention of stroke? (Editorial) Expert Rev.
Cardiovascular Ther. 1, 487489. 2003.
Macleod, M.R., Ramage, L., McGregor, A.. Seckl, J.R.
Reduced NMDA- induced apoptosis in neurons
lacking Ataxia Telangiectasia Mutated. NeuroReport,
14, 215-217. 2003.
Macleod, M.R., Lewis, S.C.. Dennis, M.S. Effect of
Deprivation on time-to-hospital in stroke. Journal of
Neurology, Neurosurgery and Psychiatry, 74, 545-546.
2003.
Macleod, M.R., Johnston, E.C., Muir, W., Blackwood, D.,
Reid, I. What happens when things go wrong. In:
Neuroscience: Science of the brain (Second Edition)
Eds. Fillenz M and Morris RG. British Neuroscience
Association. 2003.
Markus, R., Reutens, D.C., Kazui, S., Read, S.J., Wright,
P.J., Chambers, B.R., Sachinidis, J.I., Tochon-Danguy,
H.J., Donnan, G.A. The topography and temporal
evolution of hypoxic viable tissue identified by
18FFluoromisonidazole positron emission tomography
in humans following ischemic stroke. Stroke 34:2646-
2652, 2003.
2004
Macleod M, O'Collins T, Howells D, Donnan G: Response. Stroke, 2004.
Macleod MR, Amarenco P, Davis SM, Donnan GA: Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 3(7): 408-414, 2004.
Macleod MR, O'Collins T, Howells DW, Donnan GA: Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 35(5): 1203-1208, 2004.
Markus R, Donnan G, Kazui S, Read S, Reutens D: Penumbral topography in human stroke: methodology and validation of the 'Penumbragram'. Neuroimage 21(4): 1252-1259, 2004.
Markus R, Reutens DC, Kazui S, Read S, Wright P, Pearce DC, Tochon-Danguy HJ, Sachinidis JI, Donnan GA: Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival. Brain 127(Pt 6): 1427-1436, 2004.
Moodie ML, Carter R, Mihalopoulos C, Thrift AG, Chambers BR, Donnan GA, Dewey HM: Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke. Stroke 35(5): 1041-1046, 2004.
Moseley M, Donnan G: Multimodality imaging: introduction. Stroke 35(11 Suppl 1): 2632-2634, 2004.
2005
Macleod, M.R., Davis, S.M., Mitchell, P.J., Gerraty, R.P.,
Fitt, G., Hankey, G.J., Stewart-Wynne, E.G., Rosen, D.,
McNeil, J.J., Bladin, C.F., Chambers, B.R., Herkes, G.K.,
Young, D., Donnan, G.A. Results of a multicentre,
randomised controlled trial of intra-arterial urokinase in
the treatment of acute posterior circulation ischaemic
stroke. Cerebrovascular Disease 20:12-17, 2005.
Macleod, M.R., O’Collins, T., Horky, L.L., Howells, D.W.,
Donnan, G.A. Systematic review and meta-analysis of
the efficacy of melatonin in experimental stroke.
Journal of Pineal Research 38:35-41, 2005.
Macleod, M.R., O’Collins,T., Horky, L.L,, Howells, D.W.,
Donnan, G.A. Systematic review and metaanalysis of
the efficacy of FK506 in experimental stroke. J Cereb
Blood Flow Metab. 25(6):713-21, 2005.
2005
Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, Stewart-Wynne EG, Rosen D, McNeil JJ, Bladin CF, Chambers BR, Herkes GK, Young D, Donnan GA: Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 20(1): 12-17, 2005.
Macleod MR, O'Collins T, Horky LL, Howells DW, Donnan GA: Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res 38(1): 35-41, 2005.
Macleod MR, O'Collins T, Horky LL, Howells DW, Donnan GA: Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab 25(6): 713-721, 2005.
Mihalopoulos C, Cadilhac DA, Moodie ML, Dewey HM, Thrift AG, Donnan GA, Carter RC: Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): an Australian economic model for stroke. Int J Technol Assess Health Care 21(4): 499-505, 2005.
2006
Moodie M, Cadilhac D, Pearce D, Mihalopoulos C, Carter R, Davis S, Donnan G: Economic Evaluation of Australian Stroke Services. A Prospective, Multicenter Study Comparing Dedicated Stroke Units With Other Care Modalities. Stroke, 2006.
2007
Mastos M, Miller K, Eliasson AC, Imms C: Goal-directed training: linking theories of treatment to clinical practice for improved functional activities in daily life. Clin Rehabil 21(1): 47-55, 2007.
Mosley I, Nicol M, Donnan G, Patrick I, Dewey H: Stroke Symptoms and the Decision to Call for an Ambulance. Stroke 38: 361-366, 2007.
Mosley I, Nicol M, Donnan G, Patrick I, Kerr F, Dewey H: The impact of ambulance practice on acute stroke care. Stroke 38(10): 2765-2770, 2007.
N
1984
Norris
JW, Chambers BR, Shurvell BL, Hachinski VC. Outcome of brainstem strokes.
In Berguer R, Bauer RB (eds), Vertebrobasilar Arterial Occlusive Disease.
Raven Press, New York, 1984, pp37-44.
1991
Norris
JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic
carotid stenosis. Stroke 1991; 22: 1485-1490.
1998
Ng, W.K., Goh K.J., George, J., Tan, C.T., Baird, A., Donnan, G.A.
A comparative study of stroke subtypes between Asians and Caucasians
in two hospital-based stroke registries. Neurol J Southeast Asia 3:19-26,
1998.
2003
Nelson, M.R., Reid, C.M., Beilin, L.J., Donnan, G.A.,
Johnston, C.I., Krum, H., Storey, E., Tonkin, A., McNeil,
J.J., for the ASPREE Study Group. Rationale for a trial
of low-dose aspirin for the primary prevention of
major adverse cardiovascular events and vascular
dementia in the elderly. Aspirin in Reducing Events in
the Elderly (ASPREE). Drugs Aging 20:897-903, 2003.
2004
NVDPA: Consensus statement for the prevention of vascular disease. Aust Fam Physician 33(4): 235-239, 2004.
2005
Nicol MB, Thrift AG: Knowledge of risk factors and warning signs of stroke. Vasc Health Risk Manag 1(2): 137-147, 2005.
2006
Nilupul Perera M, Ma HK, Arakawa S, Howells DW, Markus R, Rowe CC, Donnan GA: Inflammation following stroke. J Clin Neurosci 13(1): 1-8, 2006.
2007
Nicks R, DeGruyter M, Walkenhorst H, Bernhardt J: Changing practice of hemiplegic shoulder care in acute neurological patients: Implementing a best practice model (MTAHS). International Journal of Therapy and Rehabilitation 14(6): 266-273, 2007.
Nicol MB, Henadeera K and Butler L. NHMRC grant applications: a comparison of "track record" scores allocated by grant assessors with bibliometric analysis of publications. MJA. 187(6) 348-352, 2007.
O
1998
Organizing
Committees (Program, Advisory, and Local). Asia Pacific Consensus
Forum on Stroke Management. Stroke 1998; 29: 1730-6.
2006
O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW: 1,026 experimental treatments in acute stroke. Ann Neurol 59(3): 467-477, 2006.
P
1980
Ponsford,
J.L., Donnan, G.A. Transient global amnesia—a hippocampal phenomenon?
J. Neurol., Neurosurg. & Psychiat., 43:285-287, 1980.
Ponsford,
J.L., Donnan, G.A., Walsh, K.W. Disorders of memory function in vetebrobasilar
disease. J. Clin. Neuropsychol., 2:267-276, 1980.
1988
Pentoxifylline
Study Group. Pentoxifylline in acute nonhemorrhagic stroke: a randomized,
placebo-controlled double-blind trial. Stroke 1988; 19: 716-722.
1989
Puce,
A., Berkovic, S.F., Donnan, G.A., Bladin, P.F. P300 Limbic P3 potentials,
seizure location in temporal lobe epilepsy. Ann. Neurol., 26: 377-385,
1989.
Puce,
A., Donnan, G.A., Bladin, P.F. Comparative effects of age on limbic
and scalp P3 Electroencephalogr. Clin. Neurophysiol., 74: 385-393,
1989.
1998
Phan TG, Bleasel AF. Transient loss of consciousness: diagnosis and
investigation. Modern Medicine. 1998; November: 38-47.
1999
Phan
TG, Wijdicks EFM. Intra-arterial thrombolysis in vertebrobasilar circulation
ischemia. Critical Care Clinics 1999; 15: 719-741.
Progress
Management Committee. PROGRESS - Perindopril Protection Against Recurrent
Stroke Study: Characteristics of the study popuulation at baseline.
J Hypertens 17:1647-1655, 1999.
2000
Phan
TG, Koh M, Vierkant RA, Wijdicks EFM. Hydrocephalus is a determinant
of early mortality in putaminal hemorrhage. Stroke 2000: 31: 2157-2162
Phan
TG, Koh M, Wijdicks EFM. The risk of ischemic stroke in patients who
have cessation of warfarin for intracerebral hemorrhage. Arch Neurol
2000; 57: 1710-1713 (Editorial Arch Neurol. 2000; 57: 1682-1684)
Phan
TG, O'Neill BP, Kurtin P. Post-Transplant Central Nervous System Lymphoma
(PT-PCNSL). A Clinical and Imaging Study. Neuro-oncology 2000: 2;
235-244.
Porritt,
M.J., Batchelor, P.E., Hughes, A.J., Kalnins, R., Donnan, G.A., Howells,
D.W. New dopaminergic neurons in Parkinson’s disease striatum.
Lancet 356:44-45, 2000.
PROGRESS
Management Committee. PROGRESS (Perindopril Protection Against Recurrent
Stroke Study): Regional characteristics of the study poppulation at
baseline. Journal of Hypertension 18:S13-S19, 2000.
2001
Phan
TG, Huston J,Bernstein MA, Riederer SJ, Brown RD. Contrast-enhanced
MRA of the Cervical Vessels: Experience With 422 Patients. Stroke
2001; 32: 2282-2286.
Porritt
MJ., PE. Batchelor, AJ. Hughes, R. Kalnins, GA. Donnanand DW. Howells.
New dopaminergic neurons in the Parkinson’s disease striatum.
Focus on Parkinson’s disease. 2001; 13, 48-49.
PROGRESS
Collaborative Group. Randomised trial of a perindopril-based blood
pressure lowering regimen among 6,105 patients with prior stroke or
transient ischaemic attack. Lancet 358:1033-1041, 2001.
2002
Parsons,
M.W., Barber, P.A., Chalk, J., Darby, D.G., Rose, S., Desmond, P.M.,
Gerraty, R.P., Tress, B.M., Wright, P.M., Donnan, G.A., Davis, S.M.
Diffusion and perfusion weighted MRI response to thrombolysis in stroke.
Annals of Neurology 51:28-37, 2002.
PEARLS
Study Group. A new design of polysomnography-based multi-center treatment
study for the restless legs syndrome. Clin Neurophysiol 2002; 113:
571-8.
Phan
TG, Huston J, Brown RD, Wiebers DO. Enlargement of Intracranial Saccular
Aneurysms as Determined by Serial MR Angiography. J Neurosurg 2002;
97: 1023-1028 (Editorial J Neurosurg 2002: 97:)
Phan
TG, Huston J, Campeau NG, Brown RD, Fulgham JR, Wijdicks EFM. Early
evolution of deficits in acute ischemic stroke: Mean transit time,
relative blood volume, and relative blood flow. J Stroke CerebroVascular
Dis. 2002; 11: 66-71.
Phan,
T.G., Wright, P.M., Markus, R., Howells, D.W., Davis, S.M., Donnan,
G.A. Salvaging the Ischaemic Penumbra: more than just reperfusion?
Clinical and Experimental Pharmacology and Physiology 29:1-10, 2002.
PROGRESS
Collaborative Group. Combined therapy with indapamide and perindopril
but not perindopril alone reduced the risk for recurrent stroke. ACP
Journal Club 136:51, 2002.
PROGRESS
Collaborative Group. Effects of a perindopril-based blood pressure
lowering regimen on cardiac outcomes among patients with cerebrovascular
disease. (submitted – Euro Heart Journal June 2002).
PROGRESS
Collaborative Group. Effects of blood pressure lowering with perindopril
and indapamide on dementia and severe cognitive decline in patients
with cerebrovascular disease. (submitted - JAMA Feb 2002).
PROGRESS
Collaborative Group. The effects of a perindopril-based blood pressure
lowering regimen on disability and dependency in 6,105 patients with
cerebrovascular disease. A randomised controlled trial. (submitted
– BMJ September 2002).
Phillips,
P.A., Boyle, R., Davis, S.M., Donnan, G.A., Gerraty, R.P., Hankey,
G.J., Landau, P., Read, S.J., Vedadhaghi, M. Is acute stroke care
in hospitals evidence-based? Short Report (submitted - BMJ Jan 2002).
2003
Phan, T.G., Huston, J., Campeau, N., Fulgham, J.,
Wijdicks, E.F.M. Diffusion-weighted imaging and MR
angiography in patients with vasospasm following SAH. Cerebrovascular Disease 15; 177-181, 2003.
2004
Paul, S.L., Thrift, A.G., Donnan, G.A. Smoking as a Crucial
Independent Determinant of Stroke. Tobcco Induced
Diseases Vol. 2, No. 2: 67-80 (2004) (c) PTID Society.
2005
Paul SL, Sturm JW, Dewey HM, Donnan GA, Macdonell RA, Thrift AG: Long-term outcome in the North East Melbourne Stroke Incidence Study: predictors of quality of life at 5 years after stroke. Stroke 36(10): 2082-2086, 2005.
Phan TG, Donnan GA, Wright PM, Reutens DC: A digital map of middle cerebral artery infarcts associated with middle cerebral artery trunk and branch occlusion. Stroke 36(5): 986-991, 2005.
Plummer C, Rattray K, Donnan GA, Basilli S: An unusual disease presenting at an unusual age: Susac's syndrome. J Clin Neurosci 12(1): 99-100, 2005.
Porritt M, Stanic D, Finkelstein D, Batchelor P, Lockhart S, Hughes A, Kalnins R, Howells D: Dopaminergic innervation of the human striatum in Parkinson's disease. Mov Disord 20(7): 810-818, 2005.
Porritt MJ, Batchelor PE, Howells DW: Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons. Exp Neurol 192(1): 226-234, 2005.
2006
Paul SL, Dewey HM, Sturm JW, Macdonell RA, Thrift AG: Prevalence of Depression and Use of Antidepressant Medication at 5-Years Poststroke in the North East Melbourne Stroke Incidence Study. Stroke, 2006.
Paul SL, Thrift AG: Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study. Hypertension 48(2): 260-265, 2006.
Pepper EM, Cadilhac DA, Pearce DC, Burrow J, Weeramanthri TS: Stroke among Indigenous Australians at Royal Darwin Hospital, 2001-02. Med J Aust 184(4): 195, 2006.
Phan TG, Donnan GA, Davis SM, Byrnes G: Proof-of-principle phase II MRI studies in stroke: sample size estimates from dichotomous and continuous data. Stroke 37(10): 2521-2525, 2006.
Phan TG, Donnan GA, Koga M, Mitchell LA, Molan M, Fitt G, Chong W, Holt M, Reutens DC: The ASPECTS template is weighted in favor of the striatocapsular region. Neuroimage 31(2): 477-481, 2006.
Porritt MJ, Kingsbury AE, Hughes AJ, Howells DW: Striatal dopaminergic neurons are lost with Parkinson's disease progression. Mov Disord, 2006.
2007
Phan TG, Donnan GA, Koga M, Mitchell LA, Molan M, Fitt G, Chong W, Holt M, Reutens DC: Assessment of Suitability of Thrombolysis in Middle Cerebral Artery Infarction: A Proof of Concept Study of a Stereologically-Based Technique. Cerebrovasc Dis 24(4): 321-327, 2007.
Phan TG, Fong AC, Donnan G, Reutens DC: Digital map of posterior cerebral artery infarcts associated with posterior cerebral artery trunk and branch occlusion. Stroke 38(6): 1805-1811, 2007.
2008
Pearce DC, Cadilhac DA, Pierce RJ, Thrift AG, Davids S, Donnan GA. Estimating the Prevalence of Sleep-Disordered Breathing in Community-Based, Long-Term Stroke Survivors Using a Validated Predictive Model. Cerebrovasc Dis 2008;26(4):441-446.
Q
1998
Quinn D, Markus R, Day R. Antiepileptic drug therapy. Current Therapeutics
1998; 39: 23-39.
R
1981
Richmond
JM, Chambers BR, D'Apice AJF, Whitworth JA, Kincaid-Smith P. Renal
disease and sarcoidosis. Med J Aust 1981; 2: 36-37.
1982
Rudge
P, Chambers BR. Physiological basis for enduring vestibular symptoms.
J Neurol Neurosurg and Psychiatry 1982; 45: 126-130.
1984
Rylance
P.B., I.R.F. Brown, D.W. Howells, J.A. Nisbet, A.N. Stone, J.B. Eastwood.
Relationship between vitamin A and bone disease in chronic renal failure.
Nephron 1984: 36, 131-135.
1988
Rowe,
C.C., Donnan, G.A., Bladin, P.F. Intracerebral Haemorrhage: Incidence
is Proportional to the use of Computerized Tomography. Brit. Med.
J., 297:1177-1178, 1988.
1994
Ruff,
T.A., Sherwen, S.J., Donnan, G.A. Seizure associated with mefloquine
for malaria prophylaxis. MJA 161:453, 1994.
1996
Read, S.J., Bladin, C.F., Yasaka, M., Donnan, G.A. How time dependent
is the threshold for cerebral infarction? Stroke 27:1918, 1996.
1998
Read,
S.J., Hirano, T., Abbott, D.F., Sachinidis, J.I., Tochon-Danguy, H.J.
Chan, J.G., Egan, G.F., Scott, A.M., Bladin, C.F., McKay, W.J., Donnan,
G.A. Identifying hypoxic tissue after acute ischemic stroke using
PET and 18F-Fluoromisonidazole. Neurology 51:1617-1621, 1998.
Read,
S.J., Jackson, G.D., Abbott, D.F., Syngeniotis, A., Mitchell, L.A.,
Fitt, G.R., Donnan, G.A. Experience with diffusion-weighted imaging
in an acute stroke unit. Cerebrovascular Diseases 8:135-143, 1998.
Read,
S.J., Pettigrew, L., Schimmel, L., Levi, C.R., Bladin, C.F., Chambers,
B.R., Donnan, G.A. White matter medullary infarcts: acute subcortical
infarction in the centrum ovale. Cerebrovasc Dis 8:289-295, 1998.
1999
Read,
S.J., Hirano, T., Davis, S.M., Donnan, G.A. Limiting neurological
damage after stroke: A review of pharmacological treatment options.
Drugs & Ageing 14(1):11-39, 1999.
2000
Read,
S.J., Hirano, T., Abbott, D.F., Markus, R., Sachinidis, J.I., Tochon-Danguy,
H.J., Chan, J.G., Egan, G.F., Scott, A.M., Bladin, C.F., McKay, W.J.,
Donnan, G.A. The fate of hypoxic tissue on 18F-Fluoromisonidazole
PET after ischemic stroke. Ann Neurol 48:228-235, 2000.
2005
Reddrop C, Moldrich RX, Beart PM, Farso M, Liberatore GT, Howells DW, Petersen KU, Schleuning WD, Medcalf RL: Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury. Stroke 36(6): 1241-1246, 2005.
Reid CM, Thrift AG: Hypertension 2020: confronting tomorrow's problem today. Clin Exp Pharmacol Physiol 32(5-6): 374-376, 2005.
2006
Reginella RL, Crocco T, Tadros A, Shackleford A, Davis SM: Predictors of stroke during 9-1-1 calls: opportunities for improving EMS response. Prehosp Emerg Care 10(3): 369-373, 2006.
2008
Randall, M., Imms, C. Carey, L. Establishing validity of a modified Melbourne Assessment for children aged 2 to 4 years. The American Journal of Occupational Therapy. 62(4): 373-383. [IF = 0.713] 2008.
S
1982
Scrimgeour EM, Chambers BR, Kaven JA. A probable case of ocular angiostrongyliasis
in New Britain, Papua New Guinea. Trans R Soc Trop Med Hyg 1982; 76:
538-540.
1986
Smith I., D.W. Howells, K. Hyland. Pteridines and Mono-amines: Relevance
to neurological damage. Postgraduate Medical Journal 1986: 62, 113-123.
1991
Silagy,
C.A., Campion, K., McNeil, J.J., Donnan, G.A., Tonkin, A.M., Worsam,
B. Comparison of recruitment strategies for a large-scale clinical
trial in the elderly. J. Clin. Epidemiol., 44:1105-1114, 1991.
1992
Silagy,
C., McNeil, J.J., Bulpitt, C.J., Donnan, G.A., Tonkin, A.M., Worsam,
B. Rationale for a primary prevention study using low-dose aspirin
to prevent coronary and cerebrovascular disease in the elderly. J.
Amer. Ger. Soc., 39:484-491, 1992.
Silagy,
C.A., Campion, K., Salem, H.H., Robert, J., McNeil, J.J., Donnan,
G.A., Tonkin, A.M., Worsam, B. Haematological profile of health in
elderly Australians. Med. J. Aust., 157:96-100, 1992.
1993
Silagy,
C.A., McNeil, J.J., Donnan, G.A., Tonkin, A.M., Wonsam, B., Campion,
K. Adverse effects of low dose aspirin in an elderly population. Clin.
Pharmacol. & Therap. 54:84-89, 1993.
Smooker
P.M., D.W. Howells, I. Dianzani, R.G. Cotton. The spectrum of mutations
in dihydropteridine reductase deficiency. Adv. Exp. Med. Biol. 1993;338:135-8.
Smooker
P.M., D.W. Howells, R.G.H. Cotton.. Mutations causing dihydropteridine
reductase deficiency. Identification of disease causing mutations
and analysis of their effects by in vitro expression of mutant proteins.
Biochemistry. 1993 32: 6443-6449.
1994
Silagy,
C.A., McNeil, J.J., Donnan, G.A., Tonkin, A.M., Worsam, B., Campion,
K. The PACE pilot study: Twelve months results and implications for
future primary prevention trials in the elderly. J. Amer. Geriatrics
Soc. 42(6):643-649, 1994.
1997
Smith
I., D.W. Howells, B. Kendall, R. Levinsky, K.Hyland. Folate deficiency
and demyelination in AIDS. Lancet 1987: 2, 215.
1998
Srikanth,
V., Donnan, G.A. Stroke: A Current Perspective. Current Therapeutics
(featured article) Dec:39-45, 1998.
Sturm,
J.W., Donnan, G.A. Diagnosis and investigation of headache. Aust Fam
Physician 27:587-589, 1998.
2002
Stork,
J.L., Kimura, K., Levi, C.R., Chambers, B.R., Abbott, A.L., Donnan,
G.A. Source of microembolic signals in patients with high grade carotid
stenosis. Stroke 33:2014-2018, 2002.
Stork,
J.L., Levi, C.R., Chambers, B.R., Abbott, A.L., Donnan, G.A. Possible
determinants of early microembolism following carotid endarterectomy.
Stroke 33:2082-2085, 2002.
Sturm
J, Dewey HM, Donnan GA, Macdonell RAL, McNeil JJ, Thrift AG. Handicap
after stroke: how does it relate to disability, perception of recovery,
and stroke subtype? The North East Melbourne Stroke Incidence Study
(NEMESIS). Stroke 33:762-768, 2002.
Sturm,
J., Vedadhaghi, M., O’Sullivan, J., Davis, S.M., Donnan, G.A.
The avoid stroke as soon as possible (ASAP) General Practice Stroke
Audit 2000. MJA 176:312-317, 2002.
Sturm,
J.W., Osborne, R.H., Dewey, H.M., Donnan, G.A., Macdonell, R.A.L.,
Thrift, A.G. Brief comprehensive quality of life assessment after
stroke: the Assessment of Quality of Life (AqoL) instrument in the
North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 33:2888-2894,
2002.
2003
Srikanth, V., Donnan, G.A. Cerebrovascular System and
the Ageing Brain. The Ageing Brain (Ed. P. Sachdev),
Swets and Zeitlinger 2003.
Siritho, S., Thrift, A.G., McNeil, J.J., You, R.X., Davis,
S.M., Donnan, G.A. Risk of ischemic stroke among
users of the oral contraceptive pill. The Melbourne
Risk Factor Study (MERFS) Group. Stroke 34:1575-1580, 2003.
Spratt, N. J., Blackie, J. D. et al. “An unusual case of “optic neuritis”.” Journal of Clinical Neurosciences
10(6): 750. 2003.
Spratt, N., Wang, Y., Levi, C., Karl, N., Evans, M., Fisher,
J. A prospective study of predictors of prolonged
hospital stay and disability after stroke. Journal of
Clinical Neuroscience; 10(6):665-9. 2003.
Srikanth, V., Thrift, A.G., Saling, M.M., Anderson, J.,
Dewey, H.M., Macdonell, R.A.L., Donnan, G.A. Increased
risk of cognitive impairment 3 months after mild to
moderate first-ever stroke: a Community-Based
Prospective Study of Nonaphasic English-Speaking
Survivors. Stroke 34:1136-1143, 2003.
Srikanth
V, Thrift AG, Saling MM, Anderson J, Dewey HM, Macdonell RAL, Donnan
GA. General cognitive ability 3 months after first-ever stroke: no
difference between matched community-based cases and controls. Stroke
34(5):1136-1143, 2003.
2004
Saita K, Chen M, Spratt NJ, Porritt MJ, Liberatore GT, Read SJ, Levi CR, Donnan GA, Ackermann U, Tochon-Danguy HJ, Sachinidis JI, Howells DW: Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke. Stroke 35(4): 975-980, 2004.
Srikanth VK, Anderson JF, Donnan GA, Saling MM, Didus E, Alpitsis R, Dewey HM, Macdonell RA, Thrift AG: Progressive dementia after first-ever stroke: a community-based follow-up study. Neurology 63(5): 785-792, 2004.
Sturm JW, Donnan GA, Dewey HM, Macdonell RA, Gilligan AK, Srikanth V, Thrift AG: Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 35(10): 2340-2345, 2004.
Sturm JW, Donnan GA, Dewey HM, Macdonell RA, Gilligan AK, Thrift AG: Determinants of handicap after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 35(3): 715-720, 2004.
2005
Spratt NJ, Howells DW: Ischaemic tolerance and mitochondrial uncoupling--can we learn from the cell? Cerebrovasc Dis 19(3): 206-208, 2005.
Srikanth V, Saling MM, Thrift AG, Donnan GA: Cerebrovascular disease and dementia. Drugs Today (Barc) 41(12): 815-825, 2005.
2006
Spratt, N.J., Howells, D.W. Ischaemic tolerance and
mitochondrial uncoupling—can we learn from the
cell? Cerebrovasc Dis. 19(3):206-8. Epub 2005.
Spratt NJ, Ackerman U, Tochon-Danguy HJ, Donnan GA, Howells DW: Characterization of fluoromisonidazole binding in stroke. Stroke 37(7): 1862-1867, 2006.
Spratt NJ, Fernandez J, Chen M, Rewell S, Cox S, van Raay L, Hogan L, Howells DW: Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods 155(2): 285-290, 2006.
Srikanth V, Saling MM, Thrift AG, Donnan GA: Cerebrovascular disease and dementia. Timely Top Med Cardiovasc Dis 10: E9, 2006.
Srikanth V, Thrift AG, Fryer JL, Saling MM, Dewey HM, Sturm JW, Donnan GA: The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke. Int Psychogeriatr 18(2): 295-305, 2006.
Srikanth VK, Quinn SJ, Donnan GA, Saling MM, Thrift AG: Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a population-based first-ever stroke cohort. Stroke 37(10): 2479-2483, 2006.
2007
Sena E, van der Worp HB, Howells D, Macleod M: How can we improve the pre-clinical development of drugs for stroke? Trends Neurosci 30(9): 433-439, 2007.
2008
Seitz, R, Matyas, T.A., Carey, L.M. Neural plasticity as a basis for motor learning and neurorehabilitation. Brain Impairment. Special Issue: Stroke Rehabilitation. 9 (2):103-113. (Invited and peer reviewed). 2008.
T
1986
Timmons,
T.A., Donnan, G.A., Whisnant, J.P., Shelley, C.D., Smith, T.F. Aneurysmal
subarachnoid haemorrhage and viral infection. Arch. Neurol., 43:376-378,
1986.
1991
Thompson
G.N., W.W. Butt, F.A. Shann, D.M. Kirby, R.D. Henning, D.W. Howells,
A, Osborne. Continuous venovenous haemofiltration in the management
of acute decompensation in inborn errors of metabolism. J. Pediatr.
1991.118; 879-884.
1993
Thorburn
D.R., G.N. Thompson, D.W. Howells. A fluorimetric assay for succinic
semialdehyde dehydrogenase activity that is suitable for pre-natal
diagnosis of the enzyme deficiency. J. Inher. Metab. Dis. 1993 16:
942-949.
1994
The
OSTR Collaborative Group, The Ottawa Stroke Trials Registry Collaborative
Group and the Development of the Ottawa Stroke Trials Registry (OSTR).
Controlled Clinical Trials 15:503-511, 1994.
1995
Thrift,
A.G., Donnan, G.A., McNeil, J.J. Epidemiology of Intracerebral Haemorrhage.
Epidemiologic Reviews Vol 17, No.2:361-381, 1995.
2006
1996
Thrift
AG, McNeil JJ, Forbes A, Donnan GA. Risk factors for intracerebral
haemorrhage in the era of well-controlled hypertension. Stroke 27(11):2020-2025,
1996.
1998
Thrift
AG, McNeil JJ, Forbes A, Donnan GA. Three important subgroups of hypertensive
persons at greater risk of intracerebral hemorrhage. Hypertension
31:1223-1229, 1998.
1999
Tepper, S.J., Donnan, G.A., Dowson, A.J., Bomhof, M.A.M., Elkind,
J., Meloche, J., Fletcher, P.E., Millson, D.S. A long-term study to
maximise migraine relief with Zolmitriptan. Current Medical Research
and Opinion 15 (4):254-271, 1999.
Thrift
AG, Donnan GA, McNeil JJ. Heavy drinking, but not moderate or intermediate
drinking, increases the risk of intracerebral haemorrhage. Epidemiology
10(3):307-312, 1999.
Thrift
AG, Evans RG, Donnan GA. Hypertension and the risk of intracerebral
haemorrhage: special considerations in patients with renal disease
[invited editorial]. Nephrology Dialysis Transplantation 14:2291-2292,
1999.
Thrift
AG, McNeil JJ, Donnan GA. The risk of intracerebral haemorrhage with
smoking. Cerebrovascular Diseases 9(1):34-39, 1999.
Thrift
AG, McNeil JJ, Forbes A, Donnan GA. Risk of primary intracerebral
haemorrhage associated with aspirin and non-steroidal anti-inflammatory
drugs: case-control study. British Medical Journal 318:759-764, 1999.
2000
Thrift
AG, Dewey HM, Macdonell RAL, McNeil JJ, Donnan GA. Stroke incidence
on the East Coast of Australia: the North East Melbourne Stroke Incidence
Study (NEMESIS). Stroke 31(9):2087-2092, 2000.
2001
The
Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain
stimulation of the subthalamic nucleus or the pars interna of the
globus pallidus in Parkinson's disease. N Engl J Med 2001;345(13):956-63.
Thrift
AG, Dewey HM, Macdonell RAL, McNeil JJ, Donnan GA. Incidence of the
major stroke subtypes. Initial findings from the North East Melbourne
Stroke Incidence Study (NEMESIS). Stroke 32(8):1732-1738, 2001.
2002
Thrift
AG, Donnan GA, McNeil JJ. Reduced Risk of Intracerebral Haemorrhage
with Dynamic Recreational Exercise, but not with Heavy Work Activity.
Stroke 33(2):559-564, 2002.
Thrift
AG, McNeil JJ, Donnan GA, for the Melbourne Risk Factor Study Group.
Reduced Frequency of High Cholesterol Levels Among Patients With Intracerebral
Haemorrhage. J Clin Neurosciences 9(4):376-380, 2002.
Thrift
AG. Association between tumor necrosis receptor levels and carotid
atherosclerosis: Is the association limited to younger individuals?
[Editorial Comment] Stroke 33(1):37-38, 2002.
Thrift,
A.G., Donnan, G.A. Does tea affect cardiovascular disease? A meta-analysis.
Am J Epidemiol 156:490, discussion 490-491, 2002.
2003
The PROGRESS Collaborative Group. Effects of blood
pressure lowering with perindopril and indapamide
therapy on dementia and cognitive decline in patients
with cerebrovascular disease. Arch Intern Med
163:1069-1075, 2003.
Thrift, A.G. Minor risk factors for intracerebral
haemorrhage: the jury is still out [invited editorial
comment]. Stroke 34(8):2065-2066, 2003.
2006
Thrift AG, Dewey HM, Sturm JW, Paul SL, Gilligan AK, Srikanth VK, Macdonell RA, McNeil JJ, Macleod MR, Donnan GA: Greater incidence of both fatal and nonfatal strokes in disadvantaged areas: the Northeast Melbourne Stroke Incidence Study. Stroke 37(3): 877-882, 2006.
V
1978
Vajda,
F.J.E., Donnan, G.A., Bladin, P.F. Patterns of response to levedopa
in Parkinson's Disease. Clin. Exp. Neurol., 15:229-306, 1978.
Vajda,
F.J.E., Mihaly, G.W., Miles, J.L., Donnan, G.A., Bladin, P.F. Rectal
administration of sodium valproate in status epilepticus. Neurology,
28:879-899, 1978.
1981
Vajda FJE, Chambers BR, Bladin PF. Brain impairment in Parkinson's
Disease: a preliminary communication. In "Brain Impairment".
Ed Broe G A, Tate R L. Supplement to Bull Post Grad Comm Med, University
of Sydney, Sydney, 1981; 164-167.
Vajda
FJE, Chambers BR. Differentiating between organic and functional seizures,
a common diagnostic problem. Aust Fam Phys 1981; 10: 960-965.
Vajda,
F. J., Donnan, G. A., Phillips, J., Bladin, P. F. Human brain, plasma,
and cerebrospinal fluid concentration of sodium valproate after 72
hours of therapy. Neurology, 31:486-4877, 1981.
1982
Vajda,
F.J.E., Donnan, G.A., Miles, J.L., Bladin, P.F. Human brain, plasma
and CFS concentrations of sodium valproate after 72 hours of therapy.
Neurology, 32:49-56, 1982.
1986
Vajda,
F.J.E., Donnan, G.A., Woodward, J.M. Management of subarachnoid haemorrhage.
Aust. J. Hosp. Pharm., 16:95-100, 1986.
2005
van der Walt A, Gilligan AK, Cadilhac DA, Brodtmann AG, Pearce DC, Donnan GA: Quality of stroke care within a hospital: effects of a mobile stroke service. Med J Aust 182(4): 160-163, 2005.
2007
van der Worp H, Sena ES, Donnan GA, Howells DW, Macleod MR: Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain, 2007.
W
1987
Willis
G.L., Donnan, G.A. Histochemical, biochemical and behavioural consequences
of MPTP treatment in C-57 black mice. Brain Res., 402:269-274, 1987.
1988
Willis
G.L., Horne M.K., Donnan, G.A. Amine accumulation, catecholamine depletion
and motor impairment in Macaca Fascicularis and the C-57 black mouse
after MPTP administration. Prog. Neuropsychopharmacol. & Biol.
Psychiat., 12:469-482, 1988.
1997
Watkins,
S., Levi, C.R., Grosset, D.G., Donnan, G.A. Doppler emboli in asymptomatic
carotid stenosis. J Neuroimaging 7:231, 1997.
Wong,
J.Y.F., Liberatore, G.T., Donnan, G.A., Howells, D.W. Expression of
brain-derived neurotrophic factor and TrkB neurotrophin receptors
after striatal injury in the mouse. Experimental Neurology 148:83-91,
1997.
1998
Watkins,
S., Levi, C.R., Grosset, D.G., Kay, J.W. Donnan, G.A. Transcranial
Doppler detected cerebral microembolic in asymptomatic carotid artery
stenosis and in healthy elderly volunteers. Cerebrovasc Dis 8(suppl
3):9, 1998.
2000
Wales L & Bernhardt J. A case for slow to recover rehabilitation
services following severe acquired brain injury. Australian Journal
of Physiotherapy 46; 143-146, 2000.
2003
Wang, Y., Levi, C., Attia, R.J., D’este, C.A., Spratt, N.,
Fisher, J. Seasonal variation of stroke in the Hunter
Region, Australia. A five-year hospital-based study.
Stroke.;34:1144-50. 2003.
Wing, L.M.H., Reid, C.M., Ryan, P., et al. A comparison
of outcomes with angiotensin-converting-enzyme
inhibitors and diuretics for hypertension in the elderly.
New England Journal of Medicine 348:583- 592,
2003.
2007
Weber A, Jones EF, Zavala JA, Ponnuthurai FA, Donnan GA: Intraobserver and Interobserver Variability of Transesophageal Echocardiography in Aortic Arch Atheroma Measurement. J Am Soc Echocardiogr, 2007.
Weir L, Cadilhac D: Managing a stroke unit: an example from Australia wih an emphasis on nursing roles. International Journal of Stroke 2(3): 201-207, 2007.
Y
1991
You,
R.X., McNeil, J.J., Farish, S.J., O'Malley, H.M., Donnan, G.A. The
influence of age on atrial fibrillation as a risk factor for stroke.
Clin. Exp. Neurol., 28:37-42, 1991.
1993
You,
R.X., McNeil, J.J., Hurley, S.F., Farish, S.J., O'Malley, H.M., Quang,
L., Donnan, G.A. Smoking as a risk factor for cortical ischaemia presumably
due to carotid occlusive disease. Neuroepidemiology, 12:141-147, 1993.
1995
You,
R.X., Donnan, G.A. Serum risk factors for stroke. Cardiovascular Risk
Factors Vol 5, No.6:348-370, 1995.
You,
R.X., McNeill, J.J., Davis, S.M., Donnan, G.A. Risk factors for lacunar
infarction syndromes. Neurology 45:1483-1487, 1995.
1997
You
RX, McNeil JJ, O’Malley HM, Davis SM, Thrift AG, Donnan GA. Risk
factors for stroke due to cerebral infarction in young adults. Stroke
28(10):1913-1918, 1997.
1998
Yasaka, M., O’Keefe, G.J., Chambers, B.R., Davis, S.M., Infeld,
B., O’Malley, H., Baird, A.E., Hirano, T., Donnan, G.A. for the
ASK (Australian Streptokinase Trial) Study Group. Streptokinase in
acute stroke: effect on reperfusion and recanalisation. Neurology
50:626-632, 1998.
Yasaka,
M., Read, S.J., O’Keefe, G.I., Egan, G.F., Pointon, O., McKay,
W.J., Donnan, G.A. Positron Emission Tomography in Ischaemic Stroke:
Cerebral Perfusion and Metabolism after Stroke Onset. J Clin Neurosci
5(4):413-416, 1998.
1999
You
RX, Thrift AG, McNeil JJ, Davis SM, Donnan GA. Ischemic stroke risk
and passive exposure to spouses’ cigarette smoking. Melbourne
Stroke Risk Factor Study (MERFS) Group. American Journal of Public
Health 89(4):572-575, 1999.
Books or Chapters
A
1983
Ackerman, R.H., Alpert, N.M., Correia, J.A., Heros, R.C., D'Alton,
J.G., Donnan, G.A., et al. Positron emission tomography in cerebrovascular
ischaemic disease. In: Functional Radionuclide Imaging of the Brain.
Ed: Magistretti P.L. Raven Press, NY, pp.277-280, 1983.
1985
Ackerman,
R.H., Correia, J.A., Alpert, N.M., D'Alton, J.G., Donnan, G.A., Davis,
S.M., Kelley, R.E., Haley, E.C., Buxton, R.B., Taveras, J.M. Positron
imaging in ischaemic and hemorrhagic stroke disease. In: The Metabolism
of the Human Brain Studies with Positron Emission Tomography. Eds:
Greitz, T., Inevar, D., Widen, L. Raven Press, New york, pp.3887-397,
1985.
B
1986
Brooder,
R.J., Chambers, B.R., Donnan, G.A. Stroke register and computer data
Base. Ibid. pp.101-110, 1986.
1993
Baird, A.E., Donnan, G.A., Austin M., Fitt, G.J., McKay, W.J. HMPAO
SPECT measures reperfusion after thrombolytic therapy in acute stroke.
In: Thrombolytic Therapy in Acute Ischemic Stroke II. Eds: del Zoppo,
G.J., Mori E, Hacke W. Springer-Verlag, Berlin, Heidelberg, pp. 301-303,
1993.
1995
Baird,
A.E., Donnan, G.A., Austin, M.C., McKay, W.J. Reperfusion in patients
with the Spectacular Shrinking Deficit demonstrated by 99mTc-hexamethylpropyleneamine
oxime single photon emission computed tomography. In: Thrombolytic
Therapy in Acute Ischemic Stroke III. (Eds). Yamaguchi, T., Mori,
E., Minematsu, K., del Zoppo, G.J. Springer-Verlag Tokyo 1995.
2003
Brodtmann, A., Darby, D., Carey, L. Functional
magnetic imaging in stroke, MRI in Stroke edited by
Stephen Davis and Steven Warach, Cambridge
University Press, UK, pp 251-262, 2003.
2004
Bernhardt J, Hill K: We only treat what it occurs to us to assess: The importance of knowledge based assessment, in Refshauge K, Ada L, Ellis E, (eds): Science-based rehabilitation: Theories into practice Edinborough, Elsevier Butterworth Heinemann, pp 15-48, 2004.
Macleod M, Mumford C: Neurological Disease, in Axford J, C OC, (eds): Medicine (Second Edition) Oxford, Blackwell Science, pp 867-958, 2004.
Srikanth V, Thrift A, Saling M, Donnan G: Early risk of cognitive impairment after a single nonaphasic stroke - findings from a community based study, in Vellas B, (ed): Research and practice in Alzheimer's diseaseSpringer Publishing Company, pp 140-146, 2004.
C
1993
Carey, L. M. (1993). Tactile and proprioceptive discrimination loss
after stroke: Training effects and quantitative measurement. PhD thesis,
La Trobe University, Melbourne.
Chambers,
B., O'Malley, H., Levi, C., Baird, A., Singh, P., Donnan, G.A. Measurement
of Recanalisation with Transcranial Doppler in Ischaemic Stroke. In:
New Horizons in Epilepsy and Stroke. A Festschrift for Dr. Peter Bladin
(Ed: Dr. Richard Macdonell), Melbourne, Australia Nov 11-13, 1993.
2000
Carey,
L., & Matyas, T. A. (2000). Somatosensory discrimination after
stroke: Stimulus specific versus generalisation training. In Bennett,
K. M. B. and Gregory, S. J. Perception and Cognition for Action: Proceedings
from the III Perception for Action Conference. Melbourne, Australia.
Cleveland Digital: 61-74.
2006
Carey L: Loss of somatic sensation, in Selzer M, Clarke S, Cohen L, Duncan p, Gage F, (eds): Textbook of neural repair and rehabilitation Cambridge, Cambridge University Press, pp 231-247, 2006.
2008
Cadilhac DA, Moodie ML, Lalor EE. DALYs and Public Health Programs for Stroke: Australian perspectives. In: Preedy V, editor. Handbook of Disease Burdens and Quality of Life Measures.: Springer, 2008.
D
1980
Donnan,
G.A. Lacunar infarction syndromes. Thesis, Doctor of Medicine, University
of Melbourne, 1980.
1982
Doyle,
A.E., Donnan, G.A. Hypertension and the Brain. In: Hypertensive Cardiovascular
Disease: Pathophysiology and Treatment. Eds: Amery, A., Fagard, R.,
Lijnon, P. and Staessen, J. Martinus Nijhoff, The Hague, pp.388-404,
1982.
1983
Donnan,
G.A. Positron emission tomography in partial epilepsy. In: Refractory
Epilepsy. Eds: Vajda, F.J.E., Donnan, G.A., York Press, Melbourne,
pp.69-72, 1983.
1984
Donnan,
G.A. Are some lacunar syndromes caused by emboli? In: Problem areas
in Acute Stroke Management. Eds: Donnan, G.A., Vajda, F.J.E., York
Press, Melbourne, pp.19-28, 1984.
Donnan,
G.A. Positron emission tomography in stroke disease. In: Problem Areas
in Acute Stroke Management. Eds: Donnan, G.A., Vajda, F.J.E. York
Press, Melbourne, pp.54-61, 1984.
Donnan,
G.A. The stroke unit team. Ibid. pp.168, 1984.
1985
Donnan,
G.A. Positron Emission Tomography in the Generalised Epilepsies. In:
Grey Areas in Epilepsy. Eds: Vajda F.J.E., Donnan G.A., York Press,
Melbourne, pp. 37-40, 1985.
Donnan,
G.A., Gossat, L.A. Nocturnal seizure monitoring - Is it worthwhile?
In: Grey Areas in Epilepsy. Eds: Vajda, F.J.E., Donnan, G.A. York
Press, Melbourne, pp.85-94, 1985.
Donnan,
G.A., Kaczmarczyk, S.J. MPTP and Parkinsonism. In: Deprenyl: Current
Status, Clinical and Pharmacological Aspects. Eds: Vajda, F.J.E.,
Donnan, G.A. York Press, Melbourne, pp.51-57, 1985.
1986
Donnan,
G.A., Rowe, C.C. Cerebral haemorrhage: A brighter outlook? In: Perspectives
in Stroke. Eds: Donnan G.A. Vajda F.J.E. York Press, Melbourne, pp.15-20,
1986.
1987
Donnan,
G.A. In Hospital Stroke and TIA recurrence rates. Ibid. pp.119-125,
1987.
1988
Donnan,
G.A., Kaczmarczyk, S.J., McKenzie, J.S., Kalnins, R.M., Mendelsohn,
F.A.O. The distribution of catecholamine uptake sites in mouse brain.
In: Pharmacology and Functional Regulation of Dopaminergic Neurons.
Eds: Beart P.M., Woodruff G.N., Jackson D.M. McMillan Press, London
pp.251-253, 1988.
1989
Donnan,
G.A. Atrial fibrillation and stroke. Ibid. pp.89-92, 1989.
Donnan,
G.A. Smoking as a risk factor for stroke. In: Stroke. Eds: Donnan
G.A., Vajda F.J.E., Berkovic S.F. Melbourne University Printing Services,
pp.73-76, 1989.
1991
Donnan, G.A. What is a stroke? In: After a Stroke. Ed. Australian Brain Foundation, Simon and Schuster pp.9-36, 1991.
1993
Donnan G.A., Davis, S.M., Baird, A.E., Chambers, B.R., Gates, P.C., Stewart-Wynne, E., Rosen, D., Tuck, R.R., McNeil, J.J. The Australian Streptokinase Study. In: Thrombolytic Therapy in Acute Ischemic Stroke II. Eds: del Zoppo, G.J., Mori, E., Hacke, W. Springer-Verlag, Berlin, Heidelberg, pp.80-89, 1993.
1992
Donnan,
G.A. Baird, A.E., McKay, W.J. The use of 99mTc-HMPAO SPECT in the
diagnosis and management of stroke. In: Proceedings of the Fifth Asian
and Oceanic Conference of Nuclear Medicine and Biology, Vol. 2, 693-698,
1992.
Donnan,
G.A. Mechanisms of subcortical infarction. In: Stroke in the 90's.
Eds. Donnan, G.A., Vajda, F.J.E. Melbourne University Printing Services,
pp.46-48, 1992.
Donnan,
G.A. Stroke units and acute stroke therapy. Ibid. pp.1-3, 1992.
Donnan,
G.A. Therapeutics in cerebrovascular disease. In: Neurological therapeutics.
Ed: Eadie, M.J.E., Churchill Livingstone, pp.525-548, 1992.
1994
Donnan,
G.A., You, R., Thrift, A., McNeil, J.J. Stroke in Australia: Cholesterol
as a risk factor. In: Proceedings of 1st International Workshop on
Atherosclerosis Research of Australian-Japanese Cooperation. Eds:
Yamamoto, A., Nestel, P.J. Tokyo, Japan, pp.114-117, 1994.
1995
Donnan,
G.A., Davis, S.M., Chambers, B.R., Gates, P., Stewart-Wynne, E., Rosen,
D., Tuck, R.R., McNeil, J.J., Hankey, G.J. Australian Streptokinase
Trial. In: Thrombolytic Therapy in Acute Ischemic Stroke III. (Eds).
Yamaguchi, T., Mori, E., Minematsu, K., del Zoppo, G.J. Pages 214-217,
1995.
Donnan,
G.A., Levi, C.R. Panhemispheric ischaemic stroke. In: Stroke Syndromes.
Eds: Bogousslavsky, J., Caplan, L.R. Blackwell Scientific 1995, Chapter
32, pages 300-305.
Donnan,
G.A., Norrving, B., Bamford, J.M., Bogousslavsky, J. Classification
and terminology of subcortical infarction. In: Lacunar and other subcortical
infarctions. Eds: Donnan, G.A., Norrving, B., Bamford, J.M., Bogousslavsky,
J. Oxford University Press 1995, Chapter 23, pages 233-237.
Donnan,
G.A., Norrving, B., Bamford, J.M., Bogousslavsky, J. Lacunar and other
subcortical infarctions. Eds. Oxford University Press. 1995.
Donnan,
G.A., O'Malley, H., Hurley, S., McNeil, J.J., Bladin, P.F. The capsular
warning syndrome. In: Lacunar and other subcortical infarctions. Eds:
Donnan, G.A., Norrving, B., Bamford, J.M., Bogousslasky, J. Oxford
University Press 1995, Chapter 6, pages 47-55.
1996
Donnan,
G.A. Thrombolysis in Acute Ischemic Stroke. In: Antithrombotic Therapy
in Stroke Eds. Roh, J.K., Ramani, V.N. The 2nd International Antithrombotic
Therapy Symposium - Seoul Korea 21st June 1996. Pages 36-37.
1997
Davis, S., M., Donnan, G.A., Grotta, J.F., Hacke, W. Interventional
Therapy in Acute Stroke. Eds. Blackwell Science 1997.
Davis,
S.M., Rosen, D.M., Donnan, G.A. Acute stroke management around the
world. In: Acute Stroke Treatment. Ed: Bogousslavsky. Chapter 1, Page
1-14, 1997.
Donnan,
G.A., You, R.X., Dewey, H.M., Baird, A.E., Levi, C.R. Important issues
in stroke today. In: Handbook of Hypertension, Eds Hansson, L., &
Birkenhager, W.H. Chapter 13, Page 269-281, 1997.
1998
Donnan,
G.A., Yasaka, M. Lacunes and Lacunar Syndromes. In: Cerebrovascular
Disease: Pathology, Diagnosis, and Management Vol 11. Ed. Ginsberg,
M.D., Bogouslavssky, J. Chapter 75, Pages 1090-1102, 1998 (Blackwell
Science).
Donnan,
G.A., Seizures in stroke. In: Focus on Epilepsy. Eds: Vajda F.J.E.,
Donnan G.A., Berkovic S.F., University of Melbourne Printing Services,
Melbourne, pp.11-16, 1988.
1999
Davis,
S.M., Donnan, G.A. Referral patterns in clinical trials. In: Update
in Intensive Care and Emergency Medicine Vol 27, Steiner et al (Eds):
Stroke, Springer-Verlag, 1999.
Donnan,
G.A., Thrift, A.G., Gilligan, A., Wright, P., Sturm, J., Dewey, H.,
You, R., McNeil, J.J. Alcohol and stroke. In: Conference Proceedings,
IMAG-99 (International Medical Advisory Group, Australian Associated
Brewers Inc, (Pg: 166-170), 1999.
2001
Donnan,
G.A. From Clinical Trials to Clinical Practice. In: Prevention of
Stroke. Eds. Norris, J., Hachinski, V. Oxford University Press, New
York, Pg 275-293, 2001.
2002
Donnan
GA, Wright PM, Markus R, Phan TG, Reutens DC. The Ischaemic Penumbra.
In: Davis SM, Fisher M, editors. Magnetic Resonance Imaging in Stroke:
Cambridge University Press; 2002.
Donnan, G.A., Wright, P.M., Markus, R., Phan, T.G.,
Reutens, D.C. The Ischaemic Penumbra: The Evolution
of a Concept. In: Magnetic Resonance Imaging in
Stroke. Eds. Davis, S.M., Fisher, M., Warach, S.
Cambridge University Press, UK, Chapter 15, Pg 191-206, 2003.
2006
Dewey H, Donnan G, Chambers B: Stroke, in C W, (ed): The Lancet Handbook of Treatment in Neurology Oxford, Elselvier, pp 87-116, 2006.
G
1993
Gibson, E., Korda, R., Richards, J., Donnan, G.A., Baird, A., McKay,
W.J. Language Recovery and Cerebral Blood Flow Using 99tonic-clonic-HMPAO
SPECT. In: New Horizons in Epilepsy and Stroke. A Festschrift for
Dr. Peter Bladin (Ed: Dr. Richard Macdonell), Melbourne, Australia
Nov 11-13, 1993.
H
1999
Hirano,
T., Donnan, G.A. Neurological Complications of Cardiac Surgery. In:
Ischaemic Heart Disease: Surgical Management. Eds. Buxton, B., Frazier,
B., Westaby, S. Mosby International, London 1999.
2001
Harris, A.L., Bladin, C.F., Donnan, G.A. Seizures and Stroke. Eds.
J. Bogousslavsky and L. Caplan, Cambridge University Press, Cambridge,
Pg 182-191, 2001.
2003
H., Bogousslavsky, J., Meldrum, H., Pg 347-59, 2003.
J
1993
Jones,
E., Calafiore, P., Tonkin, A., Donnan, G.A. Non-Rheumatic Atrial Fibrillation
Is Not An Independent Risk Factor For Ischaemic Stroke: The Importance
of Structural Cardiac Disease. In: New Horizons in Epilepsy and Stroke.
A Festschrift for Dr. Peter Bladin (Ed: Dr. Richard Macdonell), Melbourne,
Australia Nov 11-13, 1993.
1995
Jones,
E.F., Donnan, G.A. The proximal aorta: a source of stroke. Bailliere’s
Clinical Neurology Guest Editor V. Hachinski. Vol. 4, No. 2, Page
207-220, 1995.
M
1992
Macdonell, R.A.L., Donnan, G.A. The clinical applications of transcranial
stimulation in localization and prognosis of stroke. In: Clinical
application of magnetic transcranial stimulation. Ed: Lissens, M.A.,
Peeters Press, Leuven, Belgium, Pg 166-175, 1992.
1998
Mohr,
J.P., Donnan, G.A. Overview of Laboratory Studies. In: Stroke. Barnett,
H.J.M., Mohr, J.P., Stein BM., Yatsu FM (Eds). 3rd Edition, New York,
Churchill-Livingstone, Pg 189-194, 1998.
2001
Markus,
R., Kazui, S., Donnan, G.A. Clinical use of antiplatelet agents for
stroke prevention. In: Drug Therapy for Stroke Prevention. Bogousslavsky,
J. (Ed): Taylor and Francis Ltd, London, Pg 111-133, 2001.
Matyas, T.A., Carey, L.M., Mudie, H, Collins, M (2001). Training effects in post-ischemic recovery: Task-specificity and generalization phenomena in re-education of somatosensation and in bilateral isokinematic practice of upper limb movements. In Elsner, N & Kreutzberg, G.W. editors. The neurosciences at the turn of the century: Proceedings of the 4th meeting of the German Neuroscience Society: 28th Gottingen Neurobiology Conference. Thieme, New York.
2003
Mohr, J.P., Ma, H., Donnan, G.A. Overview of
Laboratory Studies. In: Stroke. Barnett, H.J.M., Mohr,
J.P., Stein BM., Yatsu FM (Eds). 4th Edition, New York,
Churchill-Livingstone ( 2003).
P
2003
Phan, T.G., Flemming, K.D., Huston, J. Chapter: Imaging
of aneurysms in Diagnostic and Therapeutic Imaging
of the Nervous System. Chapter 35. Editors Richard
Latchaw, John Kucharczyk, Michael Moseley, Beth
Yarbrough. Published by Mosby in 2003
Phan, T.G., Wiebers, D.O. Chapter: Asymptomatic
Carotid Stenosis in Neurological Therapeutics:
Principles and Practice. Chapter 41. Editor John
Noseworthy. Published by Martin Dunitz in 2003.
R
1986
Rowe, C.C., Donnan, G.A. Carotid Endarterectomy Mobidity and Mortality
Study, Austin Hospital. Ibid. pp.144-150, 1986.
1997
Royle,
J.P., Donnan, G.A. Impending Stroke. In: Emergency Vascular Practice,
Ed. Chant T and Barros D’Sa, Churchill-Livingstone. Chapter 5,
Page 30-37, 1997.
2005
Royle J, Donnan G, Chambers B: Role of the vascular surgeon in managing stroke, in Barros D'Sa A, Chant A, (eds): Emergency vascular and endovascular surgical practice Oxford, Oxford University Press, pp 141-147, 2005.
S
2004
Srikanth, V., Thrift, A.G., Saling, M.M., Donnan, G.A.
Early risk of cognitive impairment after a single
nonaphasic stroke. Research and Practice in
Alzheimer’s Disease 2004.
2006
Srikanth V, Saling M, Thrift A: Vascular cognitive impairment, in Gilman E, (ed): Neurobiology of Disease San Diego, Elsevier Science and Technology, pp, 2006.
Stapleton J, Thrift A, Saling M, Srikanth V: How useful are the MMSE and IQCODE in diagnosing cognitive impairment and dementia in stroke patients?, in Vellas B, Winblad B, Grundman M, Fitten L, Feldman H, Giacobinei E, Kurz A, (eds): Research and practice in alzheimer's disease New York, Springer publishing company, pp, 2006.
T
2000
Thrift, A., Gilligan, A., Donnan, G.A. Major risk factors and protective
factors: how to improve primary prevention of cerebrovascular disease.
In: Prevention of Ischemic Stroke, Eds. M. Fisher and C. Fieschi,
Martin Dunitz Publishers Ltd, London, Pg 7-26, 2000.
W
Y
1993
Yasaka, M., Read, S.J., O'Keefe, G.J., Egan, G.F., Pointon, O., McKay,
W.J., Donnan, G.A. Positron Emission Tomography In Ischaemic Stroke:
Patterns of Cerebral Perfusion and Metabolism in Relation to Time
After Stroke Onset. In: New Horizons in Epilepsy and Stroke. A Festschrift
for Dr. Peter Bladin (Ed: Dr. Richard Macdonell), Melbourne, Australia
Nov 11-13, 1993.
Reports and Guidelines
C
2004
Cadilhac D: Evalution of the New South Wales Greater Metropolitan Transition Task Force unit initiative 2003/2004. Final Report, in Melbourne, National Stroke Research Institute, pp, 2004.
Cadilhac D, Burrows J, Pantano D, Lalor E: StrokeSafe Program, September 2004 to September 215: A public health initiative to reduce the burden of stroke in our community. Public health program plan, in Melbourne, National Stroke Foundation, pp, 2004.
2005
Cadilhac D, Carter R, Thrift A, Dewey H: Investing in stroke: What are teh potential cost-offsets from the StrokeSafe program? Technical Report commissioned by the National Stroke Foundation, in National Stroke Research Institute, pp, 2005.
Cadilhac D, Pearce D: National Stroke Services Survey 2004: Survey report, in Melbourne, National Stroke Research Institute, pp, 2005.
2006
Cadilhac D: National Stroke Foundation self management program. Final results of the pilot programs., in Melbourne, National Stroke Research Institute, pp, 2006.
Cadilhac D, Carter R, Thrift A, Dewey H: Investing in stroke: What are teh potential cost-offsets from the StrokeSafe program? Technical Report, in National Stroke Research Institute, pp, 2006.
Couzos S, Boyden A, Anderson S, Cadilhac D, Hankey G: National Guide to preventive health assessment in Aboriginal and Torres Strait Islander peoples. Prevention of cardiac and vascular diseases, in National Aboriginal Community Controlled Health Organisation (NACCHO), pp, 2006.
2007
Cadilhac D: Tobacco use an stroke: estimates for New South Wales. Consultant Report, in Melbourne, National Stroke Research Institute, pp, 2007.
Cadilhac D, Dewey H: Section 9: Cost and Socioeconomic Implications., in National Stroke Foundation: Clinical Guidelines for Acute Stroke Management Melbourne, Australian Government: National Health and Medical Research Council, pp 57-62, 2007.
Cadilhac D, Hankey G, Harris D, Hillier S, Kilkenny M, Lalor E: National Stroke Audit Clinical Report, in Melbourne, National Stroke Foundation, pp, 2007.
G
2007
Gill M, Cadilhac D, Pollack M, Levi C: Evaluation of NSW rural stroke services 2006 - Phase I of the NSW rural stroke program. Evaluation Report, in NSW Health, pp, 2007.
N
2005
National Stroke Foundation. Clinical guidelines for stroke rehabilitation and recovery, in Melbourne, National Stroke Foundation, pp, 2005.
National Vascular Disease Prevention Alliance. The absolute risk project: Towards an absolute risk identification tool for coronary heart disease and stroke., in Report for the Commonwealth Government of Australia, pp, 2005.
National Aboriginal Community Controlled Health Organisation. National guide to a preventative health assessment in Aboriginal and Torres Strait Islander peoples, in South Melbourne, Royal Australina College of General Practitioners, pp 23, 2005.
National Aboriginal Community Controlled Health Organisation. Evidence base to a preventative health assessment in Aboriginal and Torres Strait Islander peoples, in South Melbourne, Royal Australian College of General Practitioners, pp 210, 2005.
R
2007
Randhawa H, Cadilhac D, Hankey G, Hillier S, Kilkenny M, Lalor E: National Stroke Audit Organisational Report: Acute Services, in Melbourne, National Stroke Foundation, pp, 2007.
S
2007
Stroke Foundation Expert Working Group. Clinical Guidelines for acute stroke management, in Melbourne, National Stroke Foundation, pp, 2007.
National Stroke Research Institute